Coronary Artery Bypass

• 

  Subject Areas on Research

  • 1985: left thoracotomy for reoperative coronary artery bypass procedures. 1993 update. 
  • 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons. 
  • 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 
  • 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 
  • 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 
  • 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. 
  • 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 
  • 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the American College of Emergency Physicians and Society for Cardiovascular Angiography and Interventions. 
  • 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 
  • 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 
  • 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery. 
  • 2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the Use of Antiplatelet Therapy. 
  • 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. 
  • 3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) trial. 
  • A Bayesian approach to aid in formulary decision making: incorporating institution-specific cost-effectiveness data with clinical trial results. 
  • A Call to Action to Improve Outcomes in Women Undergoing Surgical Coronary Revascularization. 
  • A Multicenter Pilot Study Assessing Regional Cerebral Oxygen Desaturation Frequency During Cardiopulmonary Bypass and Responsiveness to an Intervention Algorithm. 
  • A Plague on Both Your Monitors! Are Bispectral Index and Cerebral Oximetry Useful for Reducing Postoperative Cognitive Impairment? 
  • A bolus dose of 1.5 mg/kg amrinone effectively improves low cardiac output state following separation from cardiopulmonary bypass in cardiac surgical patients. 
  • A clinical prediction tool to estimate the number of units of red blood cells needed in primary elective coronary artery bypass surgery. 
  • A comparative evaluation of intrapleural and thoracic epidural analgesia for postoperative pain relief after minimally invasive direct coronary artery bypass surgery. 
  • A comparison of administrative versus clinical data: coronary artery bypass surgery as an example. Ischemic Heart Disease Patient Outcomes Research Team. 
  • A comparison of the costs of and quality of life after coronary angioplasty or coronary surgery for multivessel coronary artery disease. Results from the Emory Angioplasty Versus Surgery Trial (EAST). 
  • A decade of change--risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990-1999: a report from the STS National Database Committee and the Duke Clinical Research Institute. Society of Thoracic Surgeons. 
  • A double-blind, placebo-controlled trial of epsilon-aminocaproic acid for reducing blood loss in coronary artery bypass grafting surgery. 
  • A generalized estimator of the attributable benefit of an optimal treatment regime. 
  • A multicenter risk index for atrial fibrillation after cardiac surgery. 
  • A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting. 
  • A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions. CAVEAT-II Investigators. 
  • A multicenter, randomized trial of percutaneous coronary intervention versus bypass surgery in high-risk unstable angina patients. The AWESOME (Veterans Affairs Cooperative Study #385, angina with extremely serious operative mortality evaluation) investigators from the Cooperative Studies Program of the Department of Veterans Affairs. 
  • A new anatomic score for prognosis after cardiac catheterization in patients with previous bypass surgery. 
  • A pilot study to determine the feasibility of continuous cefazolin infusion. 
  • A population-based study of the association between coronary artery bypass graft surgery (CABG) and cognitive decline: the Cache County study. 
  • A preliminary study of the effects of cardiac procedures on cognitive performance. 
  • A randomized controlled trial of the Arctic Sun Temperature Management System versus conventional methods for preventing hypothermia during off-pump cardiac surgery. 
  • A randomized double-blinded multicenter comparison of remifentanil versus fentanyl when combined with isoflurane/propofol for early extubation in coronary artery bypass graft surgery. 
  • A randomized study would answer the question. 
  • A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST). 
  • A randomized, double-blind, placebo-controlled, multicenter study to evaluate the cardioprotective effects of MC-1 in patients undergoing high-risk coronary artery bypass graft surgery: MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery Trial (MEND-CABG) II--study design and rationale. 
  • A rationale for the use of sequential coronary artery bypass grafts. 
  • A risk score to predict bleeding in patients with acute coronary syndromes. 
  • A target for perioperative blood pressure during cardiac operations. 
  • ABO blood group and bleeding after coronary artery bypass graft surgery. 
  • ABO blood group influences transfusion and survival after cardiac surgery. 
  • ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). 
  • ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). 
  • ACCF/AHA/SCAI 2007 update of the Clinical Competence Statement on Cardiac Interventional Procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (Writing Committee to Update the 1998 Clinical Competence Statement on Recommendations for the Assessment and Maintenance of Proficiency in Coronary Interventional Procedures). 
  • ACCF/AHA/SCAI 2007 update of the clinical competence statement on cardiac interventional procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (writing Committee to Update the 1998 Clinical Competence Statement on Recommendations for the Assessment and Maintenance of Proficiency in Coronary Interventional Procedures). 
  • ACP Journal Club. Review: CABG reduces long-term mortality and morbidity more than PCI in multivessel coronary disease. 
  • ACTIVE or not, high intensity is here to stay. 
  • ASCERT: the American College of Cardiology Foundation--the Society of Thoracic Surgeons Collaboration on the comparative effectiveness of revascularization strategies. 
  • Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials. Improve Long-term Outcome with abciximab GP IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibition in STENTing. 
  • Ablation of atrial fibrillation during coronary artery bypass grafting: Late outcomes in a Medicare population. 
  • Aborted myocardial infarction in patients with ST-segment elevation: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen-3 Trial Electrocardiographic Substudy. 
  • Activated clotting time measurements and aprotinin studies. 
  • Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale. 
  • Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery. 
  • Acute lower extremity ischemia after cardiac surgery. 
  • Acute neuropsychological functioning following cardiosurgical interventions associated with the production of intraoperative cerebral microemboli. 
  • Acute renal failure following cardiac surgery. 
  • Acute results, complications, and effect of lesion characteristics on outcome with the solid-state, pulsed-wave, mid-infrared laser angioplasty system: final multicenter registry report. Holmium:YAG Laser Multicenter Investigators. 
  • Ad hoc percutaneous coronary intervention in patients with stable coronary artery disease: A report from the National Cardiovascular Data Registry CathPCI Registry. 
  • Advanced age, antithrombotic strategy, and bleeding in non-ST-segment elevation acute coronary syndromes: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. 
  • Advances in contrast echocardiography: intraoperative perfusion assessment. 
  • Advances in the approach to acute coronary syndromes. 
  • Advances in the surgical treatment of heart failure. 
  • Adverse cerebral outcomes after coronary bypass surgery. Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation Investigators. 
  • Adverse reactions of Achilles tendon xanthomas in three hypercholesterolemic patients after treatment intensification with niacin and bile acid sequestrants. 
  • African American-Caucasian American differences in aortic valve replacement in patients with severe aortic stenosis. 
  • Age effects of coronary artery bypass graft on cognitive status change among elderly male twins. 
  • Age, knowledge, preferences, and risk tolerance for invasive cardiac care. 
  • Alabama coronary artery bypass grafting project: results of a statewide quality improvement initiative. 
  • Alternative conduits for coronary revascularization: a novel approach for harvest of the lesser saphenous vein. 
  • An initial multicenter, randomized controlled trial on the safety and efficacy of acadesine in patients undergoing coronary artery bypass graft surgery. 
  • An initial multicenter, randomized controlled trial on the safety and efficacy of acadesine in patients undergoing coronary artery bypass graft surgery. SPI Research Group. 
  • An unexpected left ventricular outpouching detected during transesophageal echocardiography in a patient scheduled for coronary artery bypass graft surgery. 
  • Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial. 
  • Anesthetic induction with fentanyl and intravenous lidocaine for coronary artery surgery. 
  • Aneurysm of a saphenous vein bypass graft associated with aneurysms of native coronary arteries. 
  • Angiographic changes in vein grafts: stable surrogate or seductive siren? 
  • Angioplasty or surgery for multivessel coronary artery disease: comparison of eligible registry and randomized patients in the EAST trial and influence of treatment selection on outcomes. Emory Angioplasty versus Surgery Trial Investigators. 
  • Angiosomal Vascular Occlusions, Deep-Tissue Pressure Injuries, and Competing Theories: A Case Report. 
  • Angiotensin Receptor Blockade Improves Cardiac Surgical Outcomes in Patients With Metabolic Syndrome. 
  • Anomalous Aortic Origin of a Coronary Artery Repair Through an Anterior Minithoracotomy. 
  • Another use for transesophageal echocardiography during aortic valve bypass surgery. 
  • Anticoagulation and amiodarone for new atrial fibrillation after coronary artery bypass grafting: Prescription patterns and 30-day outcomes in the United States and Canada. 
  • Antithrombotic Therapy Following CABG: For the Patient, Not the Bypass Graft. 
  • Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. 
  • Aortic atheroma burden and cognitive dysfunction after coronary artery bypass graft surgery. 
  • Aortic clamping strategy and postoperative stroke. 
  • Aortic valve replacement for aortic stenosis in patients with left ventricular dysfunction. 
  • Aortic valve surgery and survival in patients with moderate or severe aortic stenosis and left ventricular dysfunction. 
  • Aorto-coronary bypass graft surgery in a patient on home hemodialysis. 
  • Aortocoronary bypass grafting in patients without left main stenosis. Relation of risk factors to early and late survival. 
  • Aortocoronary bypass surgery: Correlation of angiographic symptomatic and functional improvement at 1 year. 
  • Apolipoprotein E polymorphisms and age at first coronary artery bypass graft. 
  • Apolipoprotein E4 increases aortic atheroma burden in cardiac surgical patients. 
  • Applying the resource-based relative value scale to the Emory angioplasty versus surgery trial. 
  • Appropriateness of percutaneous coronary intervention: a review. 
  • Aprotinin: safe and effective only with the full-dose regimen. 
  • Are We At Risk of Depriving Patients Lifesaving Cardiac Surgery?: Implications of the ISCHEMIA Trial for Coronary Artery Bypass Graft Surgery. 
  • Arm complications after radial artery procurement for coronary bypass operation. 
  • Arrhythmia prophylaxis using propranolol after coronary artery surgery. 
  • Aspergillus clavatus endocarditis involving a normal aortic valve following coronary artery surgery. 
  • Aspirin and bleeding after coronary artery bypass grafting. 
  • Assessing flow during minimally invasive coronary artery bypass: an Allen's test equivalent. 
  • Assessing myocardial perfusion with Albunex during coronary artery bypass surgery: technical considerations and safety of aortic root injections. 
  • Assessment of myocardial perfusion during CABG surgery with two-dimensional transesophageal contrast echocardiography. 
  • Association Between Left Atrial Appendage Occlusion and Readmission for Thromboembolism Among Patients With Atrial Fibrillation Undergoing Concomitant Cardiac Surgery. 
  • Association between CK-MB Area Under the Curve and Tranexamic Acid Utilization in Patients Undergoing Coronary Artery Bypass Surgery. 
  • Association between endoscopic vs open vein-graft harvesting and mortality, wound complications, and cardiovascular events in patients undergoing CABG surgery. 
  • Association between levosimendan, postoperative AKI, and mortality in cardiac surgery: Insights from the LEVO-CTS trial. 
  • Association between n-3 fatty acid consumption and ventricular ectopy after myocardial infarction. 
  • Association between physician billing and cardiac stress testing patterns following coronary revascularization. 
  • Association of Cognitive Impairment With Treatment and Outcomes in Older Myocardial Infarction Patients: A Report From the NCDR Chest Pain-MI Registry. 
  • Association of Hospital and Physician Characteristics and Care Processes With Racial Disparities in Procedural Outcomes Among Contemporary Patients Undergoing Coronary Artery Bypass Grafting Surgery. 
  • Association of chronic lung disease with treatments and outcomes patients with acute myocardial infarction. 
  • Association of genetic polymorphisms with risk of renal injury after coronary bypass graft surgery. 
  • Association of hospital coronary artery bypass volume with processes of care, mortality, morbidity, and the Society of Thoracic Surgeons composite quality score. 
  • Association of hospital myocardial infarction volume with adherence to American College of Cardiology/American Heart Association performance measures: Insights from the National Cardiovascular Data Registry. 
  • Association of leukocyte-depleted blood transfusions with infectious complications after cardiac surgery. 
  • Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery. 
  • Association of neurocognitive function and quality of life 1 year after coronary artery bypass graft (CABG) surgery. 
  • Association of postoperative complications and outcomes following coronary artery bypass grafting. 
  • Associations between valve repair and reduced operative mortality in 21,056 mitral/tricuspid double valve procedures. 
  • Asymmetric cerebral near-infrared oximetric measurements during cardiac surgery. 
  • Atrial fibrillation and risk of postoperative complications. 
  • Atrial fibrillation correction surgery: lessons from the Society of Thoracic Surgeons National Cardiac Database. 
  • Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization. MultiCenter Study of Perioperative Ischemia Research Group. 
  • Avoiding aortic clamping during coronary artery bypass grafting reduces postoperative stroke. 
  • BARI 2D: A Reanalysis Focusing on Cardiovascular Events. 
  • Back to the future-Are we ready for a randomized trial of surgical versus percutaneous revascularization in cardiogenic shock? 
  • Back to the future: improving the use of guidelines-recommended coronary disease secondary prevention at the dawn of the precision medicine era. 
  • Balancing the Risks and Benefits of Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery. 
  • Balancing the risk of mortality and major bleeding in the treatment of NSTEMI patients - a report from the National Cardiovascular Data Registry. 
  • Baseline and 6-month costs of primary angioplasty therapy for acute myocardial infarction: results from the primary angioplasty registry. 
  • Bedside tool for predicting the risk of postoperative dialysis in patients undergoing cardiac surgery. 
  • Benefits of coronary revascularization: a failure to communicate. 
  • Better functional status in American than Canadian patients with heart disease: an effect of medical care? 
  • Biological and pharmacological aspects of perioperative hemorrhagic complications associated with oral platelet-directed antithrombotic agents. Focus on isolated coronary artery bypass grafting and oral irreversible P2Y(12) receptor antagonists. 
  • Bivalirudin for patients with acute coronary syndromes. 
  • Bivalirudin provides rapid, effective, and reliable anticoagulation during off-pump coronary revascularization: results of the "EVOLUTION OFF" trial. 
  • Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial. 
  • Bleeding during thrombolytic therapy for acute myocardial infarction: mechanisms and management. 
  • Bleeding events with abciximab in acute coronary syndromes without early revascularization: An analysis of GUSTO IV-ACS. 
  • Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial. 
  • Burden of medical co-morbidities and benefit from surgical revascularization in patients with ischaemic cardiomyopathy. 
  • Burden of preoperative atrial fibrillation in patients undergoing coronary artery bypass grafting. 
  • CABG Improves Outcomes in Patients With Ischemic Cardiomyopathy: 10-Year Follow-Up of the STICH Trial. 
  • CASE 6--2012: suspected amiodarone hepatotoxicity after cardiac surgery. 
  • CASS in retrospect: lessons from the randomized cohort and registry. Coronary Artery Surgery Study. 
  • Can "earlier biomarkers" help early biomarkers predict acute kidney injury? 
  • Candida mediastinitis after a cardiac operation. 
  • Cardiac surgery in nonagenarians and centenarians. 
  • Cardioplegia delivery: more (or less) than what you see. 
  • Cardiovascular Testing and Clinical Outcomes in Emergency Department Patients With Chest Pain. 
  • Cardiovascular research in the elderly: challenges, opportunities, and impact. 
  • Case 2-2002. Thoracic epidural anesthesia in patients with ankylosing spondylitis undergoing coronary artery surgery. 
  • Case 3--1999. Intraoperative coronary thrombosis in association with low-dose aprotinin therapy. 
  • Case 4--1997. The role of ischemic preconditioning during minimally invasive coronary artery bypass surgery. 
  • Case 4-2011: malignant hyperthermia in cardiac surgery. 
  • Case 6--1996, Traumatic aortocoronary saphenous vein graft occlusion. 
  • Case 6--1999. Off-pump coronary artery bypass graft surgery. 
  • Central nervous system injury associated with cardiac surgery. 
  • Central venous pressure after coronary artery bypass surgery: does it predict postoperative mortality or renal failure? 
  • Cerebral blood flow autoregulation is preserved after continuous-flow left ventricular assist device implantation. 
  • Cerebral emboli and serum S100beta during cardiac operations. 
  • Cerebral embolization during cardiac surgery: impact of aortic atheroma burden. 
  • Cerebral physiology of cardiac surgical patients treated with the perfluorocarbon emulsion, AF0144. 
  • Certificate of Need (CON) for cardiac care: controversy over the contributions of CON. 
  • Challenges in comparing risk-adjusted bypass surgery mortality results: results from the Cooperative Cardiovascular Project. 
  • Challenges in predicting the need for coronary artery bypass grafting at presentation in patients with non-ST-segment elevation acute coronary syndromes. 
  • Change in plasma glutamate concentration during cardiac surgery is a poor predictor of cognitive outcome. 
  • Changes in health-related quality of life in off-pump versus on-pump cardiac surgery: Veterans Affairs Randomized On/Off Bypass trial. 
  • Changes in patterns of coronary revascularization strategies for patients with acute coronary syndromes (from the CRUSADE Quality Improvement Initiative). 
  • Changes in systolic and diastolic function during multivessel off-pump coronary bypass grafting. 
  • Changing efficacy of coronary revascularization. Implications for patient selection. 
  • Changing systems for measuring activated clotting times: impact on the clinical practice of heparin anticoagulation during cardiac surgery. 
  • Changing the diagnosis of acute myocardial infarction: implications for practice and clinical investigations. 
  • Characteristics and Outcomes of Patients With History of CABG Undergoing Cardiac Catheterization Via the Radial Versus Femoral Approach. 
  • Characteristics of Patients Undergoing Cardiac Catheterization Before Noncardiac Surgery: A Report From the National Cardiovascular Data Registry CathPCI Registry. 
  • Characterization of myocardial infarction as an end point in two large trials of acute coronary syndromes. 
  • Chest pain self-management training for patients with coronary artery disease. 
  • Cholesterol Lowering and Coronary Revascularization: Finally a Marriage to Sustain? 
  • Choosing between percutaneous coronary intervention and coronary artery bypass grafting for patients with multivessel disease: what can we learn from the Arterial Revascularization Therapy Study (ARTS)? 
  • Chronic exposure to nicotine does not prevent neurocognitive decline after cardiac surgery. 
  • Chronic kidney disease in patients with non-ST-segment elevation acute coronary syndromes. 
  • Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease. 
  • Chronic obstructive pulmonary disease impact upon outcomes: the veterans affairs randomized on/off bypass trial. 
  • Claims-based cardiovascular outcome identification for clinical research: Results from 7 large randomized cardiovascular clinical trials. 
  • Clinical Characteristics and Outcomes of Patients With Myocardial Infarction and Cardiogenic Shock Undergoing Coronary Artery Bypass Surgery: Data From The Society of Thoracic Surgeons National Database. 
  • Clinical Profile and Sex-Specific Recovery With Cardiac Rehabilitation After Coronary Artery Bypass Grafting Surgery. 
  • Clinical Trials Versus Clinical Practice: When Evidence and Practice Diverge--Should Nondiabetic Patients With 3-Vessel Disease and Stable Ischemic Heart Disease Be Preferentially Treated With CABG? 
  • Clinical and Angiographic Predictors of Patient-Reported Angina 1 Year After Coronary Artery Bypass Graft Surgery. 
  • Clinical and angiographic correlates of short- and long-term mortality in patients undergoing coronary artery bypass grafting. 
  • Clinical and angiographic efficacy of a self-expanding nitinol stent in saphenous vein graft atherosclerotic disease: the Stent Comparative Restenosis (SCORES) Saphenous Vein Graft Registry. 
  • Clinical and angiographic predictors of short- and long-term ischemic events in acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial. 
  • Clinical and economic outcomes of liberal versus selective drug-eluting stent use: insights from temporal analysis of the multicenter Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) registry. 
  • Clinical characteristics and in-hospital outcomes of patients with cardiogenic shock undergoing coronary artery bypass surgery: insights from the Society of Thoracic Surgeons National Cardiac Database. 
  • Clinical characteristics and outcomes of patients with and without diabetes in the Surgical Treatment for Ischemic Heart Failure (STICH) trial. 
  • Clinical characteristics associated with poor long-term survival among patients with diabetes mellitus undergoing saphenous vein graft interventions. 
  • Clinical correlates of long-term mortality after percutaneous interventions of saphenous vein grafts. 
  • Clinical correlates of the initial and long-term cost of coronary bypass surgery and coronary angioplasty. 
  • Clinical outcome after coronary artery revascularization and lung transplantation. 
  • Clinical outcomes after hybrid coronary revascularization versus coronary artery bypass surgery: a meta-analysis of 1,190 patients. 
  • Clinical outcomes of hybrid coronary revascularization versus coronary artery bypass surgery in patients with diabetes mellitus. 
  • Clinical-outcome trials in cardiac surgery--have we primed the pump? 
  • Clopidogrel use After Myocardial Revascularization: Prevalence, Predictors, and One-Year Survival Rate. 
  • Clopidogrel use and bleeding after coronary artery bypass graft surgery. 
  • Clopidogrel-associated bleeding and related complications in patients undergoing coronary artery bypass grafting. 
  • Coagulation and fibrinolytic protein kinetics in cardiopulmonary bypass. 
  • Cognitive deficits following coronary artery bypass grafting: prevalence, prognosis, and therapeutic strategies. 
  • Cognitive function 5 years after randomization to coronary angioplasty or coronary artery bypass graft surgery. 
  • Cognitive outcomes analyses: two steps forward, one step back? 
  • Cold Agglutinin Autoantibodies in a Patient without a Visible Coronary Sinus Ostium: Strategies for Myocardial Protection without Using Retrograde Cardioplegia. 
  • Collaborative Quality Improvement Reduces Postoperative Pneumonia After Isolated Coronary Artery Bypass Grafting Surgery. 
  • Collaborative quality improvement vs public reporting for percutaneous coronary intervention: A comparison of percutaneous coronary intervention in New York vs Michigan. 
  • Combination of Goldman risk and initial cardiac troponin I for emergency department chest pain patient risk stratification. 
  • Combinations of beta-blockers and calcium channel blockers: a cause of malignant perioperative conduction disturbances? 
  • Combined TMR and mitral valve replacement via left thoracotomy. 
  • Combined rotational and directional atherectomy guided by intravascular ultrasound in an occluded vein graft. 
  • Commentary: Silent brain lesions after coronary artery bypass grafting-Reexamining the sound of silence. 
  • Commentary: Time-varying variables-predictively predictive prediction in a coronary artery bypass grafting readmission predictive model. 
  • Comparative Effectiveness of Hybrid Coronary Revascularization vs Coronary Artery Bypass Grafting. 
  • Comparative Efficacy of Coronary Revascularization Procedures for Multivessel Coronary Artery Disease in Patients With Chronic Kidney Disease. 
  • Comparative effectiveness of pharmacotherapies for prevention of atrial fibrillation following coronary artery bypass surgery. 
  • Comparative effectiveness of revascularization strategies. 
  • Comparing Consumer-Directed Hospital Rankings With STS Adult Cardiac Surgery Database Outcomes. 
  • Comparing off-pump and on-pump clinical outcomes and costs for diabetic cardiac surgery patients. 
  • Comparing risk-adjustment methods for provider profiling. 
  • Comparison of Outcomes and Costs Associated With Aspirin ± Clopidogrel After Coronary Artery Bypass Grafting. 
  • Comparison of Risk of Atrial Fibrillation in Black Versus White Patients After Coronary Artery Bypass Grafting. 
  • Comparison of analytic models for estimating the effect of clinical factors on the cost of coronary artery bypass graft surgery. 
  • Comparison of cardiac surgery volumes and mortality rates between the Society of Thoracic Surgeons and Medicare databases from 1993 through 2001. 
  • Comparison of coronary artery bypass grafting versus medical therapy on long-term outcome in patients with ischemic cardiomyopathy (a 25-year experience from the Duke Cardiovascular Disease Databank). 
  • Comparison of direct aortic and femoral cannulation for port-access cardiac operations. 
  • Comparison of early platelet activation in patients undergoing on-pump versus off-pump coronary artery bypass surgery. 
  • Comparison of long-term outcomes between older Asian and white patients with non-ST-segment elevation myocardial infarction: findings from CRUSADE-CMS database. 
  • Comparison of outcome after coronary angioplasty and coronary surgery for multivessel coronary artery disease in persons with diabetes. 
  • Comparison of predictions based on observational data with the results of randomized controlled clinical trials of coronary artery bypass surgery. 
  • Comparison of site-reported and core laboratory-reported creatine kinase-MB values in non-ST-segment elevation acute coronary syndrome (from the international trial SYNERGY). 
  • Comparison of slow oscillating versus fast balloon inflation strategies for coronary angioplasty. 
  • Comparison of the appropriateness of coronary angiography and coronary artery bypass graft surgery between Canada and New York State. 
  • Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators. 
  • Complete and incomplete revascularization at aortocoronary bypass surgery: experience with 392 consecutive patients. 
  • Composite outcomes in coronary bypass surgery versus percutaneous intervention. 
  • Con: Magnesium should not be administered to all coronary artery bypass graft surgery patients undergoing cardiopulmonary bypass. 
  • Concomitant carotid endarterectomy and cardiac surgery does not decrease postoperative stroke rates. 
  • Contemporary impact of state certificate-of-need regulations for cardiac surgery: an analysis using the Society of Thoracic Surgeons' National Cardiac Surgery Database. 
  • Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty. 
  • Contrast echocardiography: a method to visualize changes in regional myocardial perfusion in the dog model for CABG surgery. 
  • Controversies in oral antiplatelet therapy in patients undergoing aortocoronary bypass surgery. 
  • Conversion From Off-Pump Coronary Artery Bypass Grafting to On-Pump Coronary Artery Bypass Grafting. 
  • Coronary Anastomosis Simulation: Directed Interventions to Optimize Success. 
  • Coronary Artery Bypass Graft Surgery and Percutaneous Coronary Interventions in Patients With Unprotected Left Main Coronary Artery Disease. 
  • Coronary Artery Bypass Surgery Compared With Percutaneous Coronary Intervention for Proximal Left Anterior Descending Artery Treatment in Patients With Acute Coronary Syndrome: Analysis From the ACUITY Trial. 
  • Coronary Endarterectomy: Analysis of The Society of Thoracic Surgeons Adult Cardiac Surgery Database. 
  • Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction. 
  • Coronary artery bypass graft failure after on-pump and off-pump coronary artery bypass: findings from PREVENT IV. 
  • Coronary artery bypass grafting after aprotinin: are we doing better? 
  • Coronary artery bypass grafting in patients with dialysis-dependent renal failure. 
  • Coronary artery bypass grafting in the elderly. 
  • Coronary artery bypass in patients with severely depressed ventricular function. 
  • Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. 
  • Coronary bypass graft surgery: reexamining the assumptions. 
  • Coronary bypass grafting after failed elective and failed emergent percutaneous angioplasty. Relative risks of emergent surgical intervention. 
  • Coronary bypass surgery with or without surgical ventricular reconstruction. 
  • Coronary perfusion during acute myocardial infarction with a combined therapy of coronary angioplasty and high-dose intravenous streptokinase. 
  • Coronary revascularization after thrombolytic therapy for myocardial infarction: what caseloads could Canadian centres face? 
  • Coronary revascularization and circulatory support strategies in patients with myocardial infarction, multi-vessel coronary artery disease, and cardiogenic shock: Insights from an international survey. 
  • Coronary revascularization surgery after myocardial infarction: impact of bypass surgery on survival after thrombolysis. GUSTO Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. 
  • Coronary revascularization: importance of observational data. 
  • Coronary-Artery Bypass Grafting. 
  • Coronary-Artery Bypass Grafting. 
  • Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy. 
  • Coronary-artery bypass surgery in patients with left ventricular dysfunction. 
  • Correction of a saphenous vein graft to coronary vein anastamosis by selective retrograde coil-induced occlusion to arterialize the native vein. 
  • Cost analysis of aprotinin for coronary artery bypass patients: analysis of the randomized trials. 
  • Cost estimates for treatment of cardiac ischemia (from the Asymptomatic Cardiac Ischemia Pilot [ACIP] study). 
  • Cost-Effectiveness of Coronary Artery Bypass Surgery Versus Medicine in Ischemic Cardiomyopathy: The STICH Randomized Clinical Trial. 
  • Cost-effectiveness of coronary artery bypass grafting plus mitral valve repair versus coronary artery bypass grafting alone for moderate ischemic mitral regurgitation. 
  • Cost-effectiveness of revascularization strategies: the ASCERT study. 
  • Costs of revascularization over eight years in the randomized and eligible patients in the Emory Angioplasty versus Surgery Trial (EAST). 
  • Creatine kinase-MB elevation after coronary artery bypass grafting surgery in patients with non-ST-segment elevation acute coronary syndromes predict worse outcomes: results from four large clinical trials. 
  • Creation of state-level Medicare database for healthcare evaluation applications. 
  • Current knowledge of the platelet glycoprotein IIb/IIIa receptor antagonists for the treatment of coronary artery disease. 
  • Current landscape of hybrid revascularization: A report from the NCDR CathPCI Registry. 
  • Current management of mitral valve incompetence associated with coronary artery disease. 
  • Current outcomes of simultaneous carotid endarterectomy and coronary artery bypass graft surgery in North America. 
  • Current prognosis of ischemic mitral regurgitation. Implications for future management. 
  • Current status of perioperative temporary mechanical circulatory support during cardiac surgery. 
  • Cytokine secretion after cardiac surgery and its relationship to postoperative fever. 
  • Decellularized native and engineered arterial scaffolds for transplantation. 
  • Defining neuropsychological dysfunction after coronary artery bypass grafting. 
  • Depression as a risk factor for mortality after coronary artery bypass surgery. 
  • Depression as risk factor for mortality after coronary artery bypass surgery. 
  • Depression in male and female patients undergoing cardiac surgery. 
  • Depressive symptoms and outcome of coronary artery bypass grafting. 
  • Deterioration of regional wall motion immediately after coronary artery bypass graft surgery is associated with long-term major adverse cardiac events. 
  • Determinants of Variation in Pneumonia Rates After Coronary Artery Bypass Grafting. 
  • Determinants of early versus late cardiac death in patients undergoing coronary artery bypass graft surgery. 
  • Determinants of the need for early acute intervention in patients treated conservatively after thrombolytic therapy for acute myocardial infarction. TAMI-5 Study Group. 
  • Development of a clinical registry-based 30-day readmission measure for coronary artery bypass grafting surgery. 
  • Development of a novel blood-sparing agent in cardiac surgery: do we need another agent? 
  • Diabetic patients have abnormal cerebral autoregulation during cardiopulmonary bypass. 
  • Diagnostic and prognostic significance of exercise-induced premature ventricular complexes in men and women: a four year follow-up. 
  • Diastolic dysfunction in patients undergoing cardiac surgery: the role of gender and age-gender interaction. 
  • Differences between men and women in the management of unstable angina pectoris (The GUARANTEE Registry). The GUARANTEE Investigators. 
  • Differences in the profile, treatment, and prognosis of patients with cardiogenic shock by myocardial infarction classification: A report from NCDR. 
  • Differences in the treatment of myocardial infarction between the United States and Canada. A survey of physicians in the GUSTO trial. 
  • Differential Longitudinal Outcomes Following Percutaneous Coronary Intervention to the Left Internal Mammary Artery and Other Bypass Grafts of the LAD: Findings From the NCDR. 
  • Direct aortic cannulation for port-access mitral or coronary artery bypass grafting. 
  • Direct myocardial revascularization and angiogenesis--how many patients might be eligible? 
  • Does Platelet Reactivity Predict Bleeding in Patients Needing Urgent Coronary Artery Bypass Grafting During Dual Antiplatelet Therapy? 
  • Does preoperative atrial fibrillation increase the risk for mortality and morbidity after coronary artery bypass grafting? 
  • Does prior coronary angioplasty affect outcomes of surgical coronary revascularization? Insights from the STICH trial. 
  • Dollars and stents: the economics of drug-eluting stents. 
  • Donepezil for cognitive decline following coronary artery bypass surgery: a pilot randomized controlled trial. 
  • Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. 
  • Dual antiplatelet therapy for perioperative myocardial infarction following CABG surgery. 
  • Dynamic mitral regurgitation without regional wall motion abnormality. 
  • ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). 
  • Early and late quantitative angiographic results of vein graft lesions treated by excimer laser with adjunctive balloon angioplasty. 
  • Early exercise training in patients older than age 65 years compared with that in younger patients after acute myocardial infarction or coronary artery bypass grafting. 
  • Early intervention: which patients and how early? 
  • Early versus delayed invasive intervention in acute coronary syndromes. 
  • Early versus delayed, provisional eptifibatide in acute coronary syndromes. 
  • Echocardiographic analysis of dysfunctional and normal myocardial segments before and immediately after coronary artery bypass graft surgery. 
  • Economic analysis of the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT-3) study: costs of reperfusion strategies in acute myocardial infarction. 
  • Economic evaluation of bivalirudin with or without glycoprotein IIb/IIIa inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for early invasive management of acute coronary syndromes. 
  • Edifoligide and long-term outcomes after coronary artery bypass grafting: PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) 5-year results. 
  • Effect of adenosine-regulating agent acadesine on morbidity and mortality associated with coronary artery bypass grafting: the RED-CABG randomized controlled trial. 
  • Effect of aging on cerebral autoregulation during cardiopulmonary bypass. Association with postoperative cognitive dysfunction. 
  • Effect of cardiac rehabilitation on functional outcomes after coronary revascularization. 
  • Effect of clinical factors on length of stay after coronary artery bypass surgery: results of the cooperative cardiovascular project. 
  • Effect of coronary artery bypass graft surgery on survival. 
  • Effect of gender on angioplasty outcome: are we closer to the answer? 
  • Effect of modified ultrafiltration on bivalirudin elimination and postoperative blood loss after on-pump coronary artery bypass grafting: assessment of different filtration strategies. 
  • Effect of pexelizumab in coronary artery bypass graft surgery with extended aortic cross-clamp time. 
  • Effect of pexelizumab on mortality in patients with acute myocardial infarction or undergoing coronary artery bypass surgery: a systematic overview. 
  • Effect of temperature during cardiopulmonary bypass on gastric mucosal perfusion. 
  • Effect of variability in the interpretation of coronary angiograms on the appropriateness of use of coronary revascularization procedures. 
  • Effectiveness of revascularization in the Emory angioplasty versus surgery trial. A randomized comparison of coronary angioplasty with bypass surgery. 
  • Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery. 
  • Effects of C5 complement inhibitor pexelizumab on outcome in high-risk coronary artery bypass grafting: combined results from the PRIMO-CABG I and II trials. 
  • Effects of body surface area-indexed calculations in the morbidly obese: a mathematical analysis. 
  • Effects of coronary angioplasty, coronary bypass surgery, and medical therapy on employment in patients with coronary artery disease. A prospective comparison study. 
  • Effects of decreased preoperative endotoxin core antibody levels on long-term mortality after coronary artery bypass graft surgery. 
  • Effects of pyridoxal-5'-phosphate (MC-1) in patients undergoing high-risk coronary artery bypass surgery: results of the MEND-CABG randomized study. 
  • Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. 
  • Efficacy and safety of heparinase I versus protamine in patients undergoing coronary artery bypass grafting with and without cardiopulmonary bypass. 
  • Efficacy and safety of pyridoxal 5'-phosphate (MC-1) in high-risk patients undergoing coronary artery bypass graft surgery: the MEND-CABG II randomized clinical trial. 
  • Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST). 
  • Elevated Pulse Pressure, Intraoperative Hemodynamic Perturbations, and Acute Kidney Injury After Coronary Artery Bypass Grafting Surgery. 
  • Emory Angioplasty Versus Surgery Trial (EAST): design, recruitment, and baseline description of patients. 
  • Empirical use of causal inference methods to evaluate survival differences in a real-world registry vs those found in randomized clinical trials. 
  • Employment after coronary angioplasty or coronary bypass surgery in patients employed at the time of revascularization. 
  • Endoscopic harvesting device type and outcomes in patients undergoing coronary artery bypass surgery. 
  • Endoscopic versus open saphenous vein harvest: the effect on postoperative outcomes. 
  • Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery. 
  • Endovascular thoracic aortic aneurysm repair with concomitant myocardial and carotid revascularization. 
  • Endurance exercise in the presence of heart disease. 
  • Enhanced efficacy of eptifibatide administration in patients with acute coronary syndrome requiring in-hospital coronary artery bypass grafting. PURSUIT Investigators. 
  • Enlarging pseudoaneurysm of a right saphenous vein graft after emergent coronary artery bypass grafting. 
  • Epidemiology of new-onset atrial fibrillation following coronary artery bypass graft surgery. 
  • Epsilon-aminocaproic acid administration and stroke following coronary artery bypass graft surgery. 
  • Evaluating the exposure and disease relationship with adjustment for different types of exposure misclassification: a regression approach. 
  • Evaluation of The Society of Thoracic Surgeons Online Risk Calculator for Assessment of Risk in Patients Presenting for Aortic Valve Replacement After Prior Coronary Artery Bypass Graft: An Analysis Using the STS Adult Cardiac Surgery Database. 
  • Events leading to the treatment of coronary artery disease: implications for nursing care. 
  • Evolving revascularization approaches for myocardial ischemia. 
  • Exercise capacity and mortality in patients with ischemic left ventricular dysfunction randomized to coronary artery bypass graft surgery or medical therapy: an analysis from the STICH trial (Surgical Treatment for Ischemic Heart Failure). 
  • Exercise stress testing in evaluation of aortocoronary bypass surgery. Report of 123 patients. 
  • Expected and realized benefits from coronary bypass surgery in relation to severity of illness. 
  • Exploring the behavior of hospital composite performance measures: an example from coronary artery bypass surgery. 
  • Exposure to topical bovine thrombin during surgery elicits a response against the xenogeneic carbohydrate galactose alpha1-3galactose. 
  • Extent of coronary and myocardial disease and benefit from surgical revascularization in ischemic LV dysfunction [Corrected]. 
  • External Support for Saphenous Vein Grafts in Coronary Artery Bypass Surgery: A Randomized Clinical Trial. 
  • Factors contributing to the lower mortality with ticagrelor compared with clopidogrel in patients undergoing coronary artery bypass surgery. 
  • Failure to Rescue Rates After Coronary Artery Bypass Grafting: An Analysis From The Society of Thoracic Surgeons Adult Cardiac Surgery Database. 
  • Female gender is associated with impaired quality of life 1 year after coronary artery bypass surgery. 
  • First report of the Port Access International Registry. 
  • Five-Year Outcomes after On-Pump and Off-Pump Coronary-Artery Bypass. 
  • Fixing the heart: must the brain pay the price? 
  • Fondaparinux therapy in a hemodialysis patient with heparin-induced thrombocytopenia type II. 
  • Frequency and predictors of drug-eluting stent use in saphenous vein bypass graft percutaneous coronary interventions: a report from the American College of Cardiology National Cardiovascular Data CathPCI registry. 
  • Frequency, predictors, and outcomes of drug-eluting stent utilization in patients with high-risk non-ST-segment elevation acute coronary syndromes. 
  • From controlled trials to clinical practice: monitoring transmyocardial revascularization use and outcomes. 
  • From efficacy to safety concerns: a STEP forward or a step back for clinical research and intercessory prayer? The Study of Therapeutic Effects of Intercessory Prayer (STEP). 
  • Full-dose aprotinin use in coronary artery bypass graft surgery: an analysis of perioperative pharmacotherapy and patient outcomes. 
  • G protein-coupled receptor kinase 5 gene polymorphisms are associated with postoperative atrial fibrillation after coronary artery bypass grafting in patients receiving β-blockers. 
  • Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. 
  • Gender differences in the treatment of non-ST-segment elevation myocardial infarction. 
  • Gender, cardiology, and optimal medical care. 
  • Gene delivery to aortocoronary saphenous vein grafts in a large animal model of intimal hyperplasia. 
  • Gene signatures of postoperative atrial fibrillation in atrial tissue after coronary artery bypass grafting surgery in patients receiving β-blockers. 
  • Gene therapy for human bypass grafts. 
  • Genetic variants are not associated with outcome in patients with coronary artery disease and left ventricular dysfunction: results of the Genetic Substudy of the Surgical Treatment for Ischemic Heart Failure (STICH) trials. 
  • Genetic variants associated with vein graft stenosis after coronary artery bypass grafting. 
  • Genetic variants in P-selectin and C-reactive protein influence susceptibility to cognitive decline after cardiac surgery. 
  • Genome-Wide Association Study Links Receptor Tyrosine Kinase Inhibitor Sprouty 2 to Thrombocytopenia after Coronary Artery Bypass Surgery. 
  • Genome-wide association study of acute kidney injury after coronary bypass graft surgery identifies susceptibility loci. 
  • Genome-wide association study of new-onset atrial fibrillation after coronary artery bypass grafting surgery. 
  • Genome-wide association study of perioperative myocardial infarction after coronary artery bypass surgery. 
  • Geographic variation in resource use for coronary artery bypass surgery. IHD Port Investigators. 
  • Glycemic control in patients undergoing coronary artery bypass graft surgery: Clinical features, predictors, and outcomes. 
  • Great saphenous vein stump thrombosis after harvesting for coronary artery bypass graft surgery. 
  • Guidelines for carotid endarterectomy. A multidisciplinary consensus statement from the ad hoc Committee, American Heart Association. 
  • Haptoglobin Genotype as a Prognostic Factor for Adverse Events in Coronary Artery Bypass Surgery in Diabetic Patients. 
  • Has the frequency of bleeding changed over time for patients presenting with an acute coronary syndrome? The global registry of acute coronary events. 
  • Health Status after Invasive or Conservative Care in Coronary and Advanced Kidney Disease. 
  • Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease. 
  • Health-related quality of life impacts upon 5-year survival after coronary artery bypass surgery. 
  • Hemodynamic changes after protamine administration: association with mortality after coronary artery bypass surgery. 
  • Hemodynamic effects of synchronized high-frequency jet ventilation compared with low-frequency intermittent positive-pressure ventilation after myocardial revascularization. 
  • Heparin anticoagulation in patients undergoing off-pump and on-pump coronary bypass surgery. 
  • High spinal anesthesia for cardiac surgery: effects on beta-adrenergic receptor function, stress response, and hemodynamics. 
  • High-dose aprotinin effectively reduces blood loss during on-pump coronary artery bypass grafting with bivalirudin anticoagulation. 
  • Home surveillance program prevents interstage mortality after the Norwood procedure. 
  • Hospital patterns of medical management strategy use for patients with non-ST-elevation myocardial infarction and 3-vessel or left main coronary artery disease. 
  • Hospital variability in length of stay after coronary artery bypass surgery: results from the Society of Thoracic Surgeon's National Cardiac Database. 
  • How should a patient presenting with unstable angina and a recent stroke be managed? 
  • Hybrid Coronary Revascularization for the Treatment of Multivessel Coronary Artery Disease: A Multicenter Observational Study. 
  • Hypoxemia after prior cardiac surgery due to interatrial shunting and its treatment with a novel transcatheter occlusion device. 
  • Identification of patients with coronary disease at high risk for loss of employment. A prospective validation study. 
  • Identification of preoperative variables needed for risk adjustment of short-term mortality after coronary artery bypass graft surgery. The Working Group Panel on the Cooperative CABG Database Project. 
  • Identifying quality of life outcome patterns to inform treatment choices in ischemic cardiomyopathy. 
  • Identifying stunned myocardium during cardiac surgery: the role of myocardial contrast echocardiography. 
  • Identifying the cause of left ventricular systolic dysfunction after coronary artery bypass surgery: the role of myocardial contrast echocardiography. 
  • Images in cardiology. Coronary artery calcification. 
  • Immediate versus delayed coronary grafting after streptokinase treatment. Postoperative blood loss and clinical results. 
  • Impact of Intubation Time on Survival following Coronary Artery Bypass Grafting: Insights from the Surgical Treatment for Ischemic Heart Failure (STICH) Trial. 
  • Impact of chronic kidney disease on early (30-day) and late (1-year) outcomes of patients with acute coronary syndromes treated with alternative antithrombotic treatment strategies: an ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) substudy. 
  • Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery: a multicenter analysis. 
  • Impact of congestive heart failure in patients with non-ST-segment elevation acute coronary syndromes. 
  • Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. 
  • Impact of early discharge after coronary artery bypass graft surgery on rates of hospital readmission and death. The Ischemic Heart Disease (IHD) Patient Outcomes Research Team (PORT) Investigators. 
  • Impact of early renal recovery on survival after cardiac surgery-associated acute kidney injury. 
  • Impact of extracardiac vascular disease on vein graft failure and outcomes after coronary artery bypass surgery. 
  • Impact of internal mammary artery conduit on long-term outcomes after percutaneous intervention of saphenous vein graft. 
  • Impact of lipid-lowering medications and low-density lipoprotein levels on 1-year clinical outcomes after coronary artery bypass grafting. 
  • Impact of mitral valve regurgitation evaluated by intraoperative transesophageal echocardiography on long-term outcomes after coronary artery bypass grafting. 
  • Impact of perioperative myocardial infarction on angiographic and clinical outcomes following coronary artery bypass grafting (from PRoject of Ex-vivo Vein graft ENgineering via Transfection [PREVENT] IV). 
  • Impact of preoperative chronic lung disease on survival after surgical aortic valve replacement. 
  • Impact of preoperative renal dysfunction in patients undergoing off-pump versus on-pump coronary artery bypass. 
  • Impact of recovery of renal function on long-term mortality after coronary artery bypass grafting. 
  • Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database. 
  • Impact of residency status on perfusion times and outcomes for coronary artery bypass graft surgery. 
  • Impact of saphenous vein graft radiographic markers on clinical events and angiographic parameters. 
  • Impact of sex on long-term mortality from acute myocardial infarction vs unstable angina. 
  • Impact of surgical ventricular reconstruction on sphericity index in patients with ischaemic cardiomyopathy: follow-up from the STICH trial. 
  • Implantable Cardioverter Defibrillator Utilization and Mortality Among Patients ≥65 Years of Age With a Low Ejection Fraction After Coronary Revascularization. 
  • Implication of right ventricular dysfunction on long-term outcome in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting with or without surgical ventricular reconstruction. 
  • Implications of cost in treatment selection for patients with coronary heart disease. 
  • Implications of prior myocardial infarction for patients presenting with an acute myocardial infarction. 
  • Importance of baseline functional and socioeconomic factors for participation in cardiac rehabilitation. 
  • Improved survival of surgically treated patients with triple vessel coronary artery disease and severe angina pectoris. A report from the Coronary Artery Surgery Study (CASS) registry. 
  • Improving acute coronary syndrome care: the ACC/AHA guidelines and critical pathways. 
  • Improving recovery following cardiac surgery: a randomized clinical trial. 
  • In coronary artery disease, PCI increases all-cause and cause-specific mortality compared with CABG. 
  • In patients with recent ACS and uncontrolled dyslipidemia, alirocumab reduced MACE regardless of previous CABG. 
  • In vitro effects of antihypertensive drugs on thromboxane agonist (U46619)-induced vasoconstriction in human internal mammary artery. 
  • In-hospital Outcomes of Patients With and Without Previous Coronary Artery Bypass Graft Surgery Who Present With a Non-ST-Segment Elevation Myocardial Infarction. 
  • In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry. 
  • In-hospital mortality of surgical patients: is there an empiric basis for standard setting? 
  • Incidence and Prognostic Impact of Incomplete Revascularization Documented by Coronary Angiography 1 Year After Coronary Artery Bypass Grafting. 
  • Incidence and characteristics of stroke during 90-day follow-up in patients stabilized after an acute coronary syndrome. 
  • Incidence of postoperative stroke using the Heartstring device in 1,380 coronary artery bypass graft patients with mild to severe atherosclerosis of the ascending aorta. 
  • Incidence of thrombocytopenia among patients receiving heparin venous thromboembolism prophylaxis. 
  • Incidence, Characteristics, and Outcomes of Myocardial Infarction in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial. 
  • Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromes. 
  • Incidental cor triatriatum sinister during coronary artery bypass surgery. 
  • Incidental moderate mitral regurgitation in patients undergoing coronary artery bypass grafting: update on guidelines and key randomized trials. 
  • Increased Long-Term Mortality among Black CABG Patients Receiving Preoperative Inotropic Agents. 
  • Increased coronary artery disease severity in black women undergoing coronary bypass surgery. 
  • Increasing healthcare resource utilization after coronary artery bypass graft surgery in the United States. 
  • Indications, algorithms, and outcomes for coronary artery bypass surgery in patients with acute coronary syndromes. 
  • Inducible myocardial ischemia and outcomes in patients with coronary artery disease and left ventricular dysfunction. 
  • Infectious complications after cardiac surgery: lack of association with fresh frozen plasma or platelet transfusions. 
  • Influence of Baseline Characteristics, Operative Conduct, and Postoperative Course on 30-Day Outcomes of Coronary Artery Bypass Grafting Among Patients With Left Ventricular Dysfunction: Results From the Surgical Treatment for Ischemic Heart Failure (STICH) Trial. 
  • Influence of baseline left ventricular function on the clinical outcome of surgical ventricular reconstruction in patients with ischaemic cardiomyopathy. 
  • Influence of body mass index on the efficacy of revascularization in patients with coronary artery disease. 
  • Influence of crossover on mortality in a randomized study of revascularization in patients with systolic heart failure and coronary artery disease. 
  • Influence of diabetes and mammary artery grafting on survival after coronary bypass. 
  • Influence of mitral regurgitation repair on survival in the surgical treatment for ischemic heart failure trial. 
  • Influence of preoperative renal dysfunction on one-year bypass graft patency and two-year outcomes in patients undergoing coronary artery bypass surgery. 
  • Influence of the Angioplasty Revascularization Investigation National Heart, Lung, and Blood Institute Diabetic Clinical Alert on practice patterns: results from the National Cardiovascular Network Database. 
  • Influence of transducer frequency and imaging modality on the intraoperative assessment of myocardial perfusion with transesophageal echocardiography. 
  • Inhibition of complement activation by pexelizumab reduces death in patients undergoing combined aortic valve replacement and coronary artery bypass surgery. 
  • Initial Invasive or Conservative Strategy for Stable Coronary Disease. 
  • Initial functional and economic status of patients with multivessel coronary artery disease randomized in the Bypass Angioplasty Revascularization Investigation (BARI). 
  • Insights from the STICH trial: change in left ventricular size after coronary artery bypass grafting with and without surgical ventricular reconstruction. 
  • Insulin Use and Clinical Outcomes in Patients Undergoing Coronary Artery Bypass Graft Surgery. 
  • Integrative biomechanics: A paradigm for clinical applications of fundamental mechanics 
  • Integrative noetic therapies as adjuncts to percutaneous intervention during unstable coronary syndromes: Monitoring and Actualization of Noetic Training (MANTRA) feasibility pilot. 
  • Intensive Care Unit Management of the Adult with Congenital Heart Disease. 
  • Internal mammary artery graft angioplasty: acute and long-term outcome. 
  • International variation in the use of blood transfusion in patients with non-ST-segment elevation acute coronary syndromes. 
  • Intra-aortic balloon counterpulsation in US and non-US centres: results of the Benchmark Registry. 
  • Intraoperative assessment of left ventricular heterogeneity. 
  • Intraoperative contrast echocardiography. 
  • Intraoperative contrast echocardiography: a direct approach to measure regional myocardial perfusion. 
  • Intraoperative echocardiography is indicated in high-risk coronary artery bypass grafting. 
  • Intraoperative hyperglycemia and cognitive decline after CABG. 
  • Intraoperative management of severe endobronchial hemorrhage. 
  • Intraoperative perfusion contrast echocardiography. Initial experience during coronary artery bypass grafting. 
  • Intraoperative physiologic variables and outcome in cardiac surgery: Part I. In-hospital mortality. 
  • Intraoperative physiologic variables and outcome in cardiac surgery: Part II. Neurologic outcome. 
  • Intraoperative somatosensory evoked potential monitoring predicts peripheral nerve injury during cardiac surgery. 
  • Intraoperative systolic blood pressure variability predicts 30-day mortality in aortocoronary bypass surgery patients. 
  • Intravenous amiodarone or magnesium sulphate is not cost-beneficial prophylaxis for atrial fibrillation after coronary artery bypass surgery. 
  • Invited Commentary. 
  • Invited commentary. 
  • Invited commentary. 
  • Invited commentary. 
  • Invited commentary. 
  • Invited commentary. 
  • Is Off-Pump CABG Off Base? 
  • Is early too early? Effect of shorter stays after bypass surgery. 
  • Is preoperative fibrinogen predictive for postoperative bleeding after coronary artery bypass grafting surgery? 
  • Is there a long-term predictive value of intraoperative low-dose dobutamine echocardiography in patients who have coronary artery bypass graft surgery with cardiopulmonary bypass? 
  • Ischemia change in stable coronary artery disease is an independent predictor of death and myocardial infarction. 
  • Ischemic burden, treatment allocation, and outcomes in stable coronary artery disease. 
  • Ischemic cardiomyopathy: the myopathy of coronary artery disease. Natural history and results of medical versus surgical treatment. 
  • Isolated systolic hypertension is associated with adverse outcomes from coronary artery bypass grafting surgery. 
  • Jugular bulb saturation and cognitive dysfunction after cardiopulmonary bypass. 
  • Jugular bulb saturation and mixed venous saturation during cardiopulmonary bypass. 
  • LDH isoenzymes and myocardial infarction in patients undergoing coronary bypass surgery: an excellent correlation. 
  • Lambda light chain deposition disease in a renal allograft. 
  • Late Consequences of Acute Coronary Syndromes: Global Registry of Acute Coronary Events (GRACE) Follow-up. 
  • Late survival after valve operation in patients with left ventricular dysfunction. 
  • Left main coronary disease: evolving management concepts. 
  • Left main stenosis. 
  • Left ventricular function under stress before and after myocardial revascularization. 
  • Levosimendan in patients with reduced left ventricular function undergoing isolated coronary or valve surgery. 
  • Life adaptation after percutaneous transluminal coronary angioplasty and coronary artery bypass grafting. 
  • Light versus heavy sedation after cardiac surgery: myocardial ischemia and the stress response. Maritime Heart Centre and Dalhousie University. 
  • Lipid management in patients with unstable angina pectoris and non-ST-segment elevation acute myocardial infarction (from CRUSADE). 
  • Long-Term Post-Discharge Risks in Older Survivors of Myocardial Infarction With and Without Out-of-Hospital Cardiac Arrest. 
  • Long-Term Prognostic Implications of Previous Silent Myocardial Infarction in Patients Presenting With Acute Myocardial Infarction. 
  • Long-Term Survival after Cardiac Surgery in Patients with Chronic Obstructive Pulmonary Disease. 
  • Long-term Thromboembolic Risk in Patients With Postoperative Atrial Fibrillation After Coronary Artery Bypass Graft Surgery and Patients With Nonvalvular Atrial Fibrillation. 
  • Long-term clinical and angiographic outcomes in patients with diabetes undergoing coronary artery bypass graft surgery: results from the Project of Ex-vivo Vein Graft Engineering via Transfection IV trial. 
  • Long-term clinical and economic analysis of the Endeavor zotarolimus-eluting stent versus the cypher sirolimus-eluting stent: 3-year results from the ENDEAVOR III trial (Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions). 
  • Long-term follow-up assessment of a phase 1 trial of angiogenic gene therapy using direct intramyocardial administration of an adenoviral vector expressing the VEGF121 cDNA for the treatment of diffuse coronary artery disease. 
  • Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I. 
  • Long-term outcomes after invasive management for older patients with non-ST-segment elevation myocardial infarction. 
  • Long-term outcomes after transmyocardial revascularization. 
  • Long-term outcomes of the symmetry vein graft anastomosis device: a matched case-control analysis. 
  • Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease. 
  • Long-term survival of patients with ischemic cardiomyopathy treated by coronary artery bypass grafting versus medical therapy. 
  • Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. 
  • Low Volume Aerobic Training Heightens Muscle Deoxygenation in Early Post-Angina Pectoris Patients. 
  • Low serum magnesium level predicts major adverse cardiac events after coronary artery bypass graft surgery. 
  • Low-dose dobutamine tissue-tagged magnetic resonance imaging with 3-dimensional strain analysis allows assessment of myocardial viability in patients with ischemic cardiomyopathy. 
  • Lower Repeat Revascularization Rates Among Patients With Prior Coronary Artery Bypass Graft Surgery are Due to Lack of Adequate Target Vessels. 
  • Lower endotoxin immunity predicts increased cognitive dysfunction in elderly patients after cardiac surgery. 
  • Lower likelihood of cardiac procedures after acute coronary syndrome in patients with human immunodeficiency virus/acquired immunodeficiency syndrome. 
  • Lymphocyte and monocyte subset changes during cardiopulmonary bypass: effects of aging and gender. 
  • Magnesium therapy for refractory ventricular fibrillation. 
  • Maintenance of therapeutic plasma aprotinin levels during prolonged cardiopulmonary bypass using a large-dose regimen. 
  • Management and outcomes in patients with moderate or severe functional mitral regurgitation and severe left ventricular dysfunction. 
  • Management of Coronary Disease in Patients with Advanced Kidney Disease. 
  • Management of a patient with type IIC von Willebrand's disease during coronary artery bypass graft surgery. 
  • Management of coronary artery disease in end-stage renal disease. 
  • Management of postoperative atrial fibrillation and subsequent outcomes in contemporary patients undergoing cardiac surgery: insights from the Society of Thoracic Surgeons CAPS-Care Atrial Fibrillation Registry. 
  • Mayo Clinic Risk Score for percutaneous coronary intervention predicts in-hospital mortality in patients undergoing coronary artery bypass graft surgery. 
  • Measurement of myocardial perfusion by contrast echocardiography: application in the operating room. 
  • Measuring hospital mortality rates: are 30-day data enough? Ischemic Heart Disease Patient Outcomes Research Team. 
  • Mediastinitis after coronary artery bypass graft surgery. Risk factors and long-term survival. 
  • Medical and surgical management of coronary artery disease in women. 
  • Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. Bypass Angioplasty Revascularization Investigation (BARI) Investigators. 
  • Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease. 
  • Medical economics and the assessment of value in cardiovascular medicine: Part II. 
  • Medical therapies and invasive treatments for coronary artery disease by body mass: the "obesity paradox" in the Get With The Guidelines database. 
  • Medication performance measures and mortality following acute coronary syndromes. 
  • Meta-analysis of minimally invasive coronary artery bypass versus drug-eluting stents for isolated left anterior descending coronary artery disease. 
  • Metabolic profiles predict adverse events after coronary artery bypass grafting. 
  • Methodological issues in the assessment of neuropsychologic function after cardiac surgery. 
  • Metoprolol and coronary artery bypass grafting surgery: does intraoperative metoprolol attenuate acute beta-adrenergic receptor desensitization during cardiac surgery? 
  • Minitransseptal versus left atrial approach to the mitral valve: a comparison of outcomes. 
  • Mitral flow propagation velocity identifies patients with abnormal diastolic function during coronary artery bypass graft surgery. 
  • Modifiable risk factors control and its relationship with 1 year outcomes after coronary artery bypass surgery: insights from the REACH registry. 
  • Modulation of phosphatidylinositol 3-kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts. 
  • Molecular approaches for the treatment of atherosclerosis. 
  • Monitoring direct thrombin inhibitors: time for standardization. 
  • Monitoring nursing interventions and data collection in a randomized clinical trial. 
  • More on the GUSTO Trial. 
  • Mortality and need for reoperation in patients with mild-to-moderate asymptomatic aortic valve disease undergoing coronary artery bypass graft alone. 
  • Mortality benefit with prasugrel in the TRITON-TIMI 38 coronary artery bypass grafting cohort: risk-adjusted retrospective data analysis. 
  • Mortality trends associated with acute renal failure requiring dialysis after CABG surgery in the United States. 
  • Multicenter experience in revascularization of very elderly patients. 
  • Multicenter preoperative stroke risk index for patients undergoing coronary artery bypass graft surgery. Multicenter Study of Perioperative Ischemia (McSPI) Research Group. 
  • Multicenter study of target-controlled infusion of propofol-sufentanil or sufentanil-midazolam for coronary artery bypass graft surgery. Multicenter Study of Perioperative Ischemia (McSPI) Research Group. 
  • Multinational institutional survey on patterns of intraoperative transesophageal echocardiography use in adult cardiac surgery. 
  • Multivessel coronary artery disease and poor left ventricle function: It is consistent and clear, coronary artery bypass grafting wins again. 
  • Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons. 
  • Myocardial Viability and Long-Term Outcomes in Ischemic Cardiomyopathy. 
  • Myocardial depression by anesthetic agents (halothane, enflurane and nitrous oxide): quantitation based on end-systolic pressure-dimension relations. 
  • Myocardial infarction following coronary artery bypass graft surgery increases healthcare resource utilization. 
  • Myocardial protection isn't dead yet. 
  • Myocardial salvage after failed coronary angioplasty. 
  • Myocardial viability and impact of surgical ventricular reconstruction on outcomes of patients with severe left ventricular dysfunction undergoing coronary artery bypass surgery: results of the Surgical Treatment for Ischemic Heart Failure trial. 
  • Myocardial viability and survival in ischemic left ventricular dysfunction. 
  • Myocardial viability in ischemic left ventricular dysfunction. 
  • Myonecrosis after revascularization procedures. 
  • N-terminal pro-brain natriuretic peptide and outcomes in patients undergoing surgical ventricular restoration. 
  • Native coronary disease progression exceeds failed revascularization as cause of angina after five years in the Bypass Angioplasty Revascularization Investigation (BARI). 
  • Natural history of cerebral complications of coronary artery bypass graft surgery. 
  • Neurocognitive dysfunction following cardiac surgery. 
  • Neurocognitive function after coronary-artery bypass surgery. 
  • Neurologic outcomes after coronary artery bypass grafting with and without cardiopulmonary bypass. 
  • Neuroprotection is associated with beta-adrenergic receptor antagonists during cardiac surgery: evidence from 2,575 patients. 
  • Neutrophil CD11b upregulation during cardiopulmonary bypass is associated with postoperative renal injury. 
  • New paradigms in cardiovascular medicine: emerging technologies and practices: perioperative genomics. 
  • New-onset postoperative atrial fibrillation impact on 5-year clinical outcomes and costs. 
  • Nitrous oxide for blood pressure control after coronary artery surgery: a dose-response hemodynamic study in postoperative patients. 
  • No Association of Early Postoperative Heart Rate With Outcomes After Coronary Artery Bypass Grafting. 
  • No association between donor age and recipient outcomes: transfusion of plasma in patients undergoing coronary artery bypass grafting surgery. 
  • Non-ST-elevation myocardial infarction patients who present during off hours have higher risk profiles and are treated less aggressively, but their outcomes are not worse: a report from Can Rapid Risk Stratification of Unstable Angina Patients Suppress ADverse Outcomes with Early Implementation of the ACC/AHA Guidelines CRUSADE initiative. 
  • Non-evidence-based ICD implantations in the United States. 
  • Nonsteroidal Anti-Inflammatory Drugs and Clinical Outcomes in Patients Undergoing Coronary Artery Bypass Surgery. 
  • Observational comparison of event-free survival with medical and surgical therapy in patients with coronary artery disease. 20 years of follow-up. 
  • Off-pump bypass surgery--ready for the big dance? 
  • Off-pump coronary artery bypass grafting. Excellent results in a group of selected high-risk patients. 
  • Off-pump coronary artery bypass surgery in a patient with C1 esterase inhibitor deficiency. 
  • Off-pump coronary bypass provides reduced mortality and morbidity and equivalent 10-year survival. 
  • Off-pump or on-pump coronary-artery bypass grafting. 
  • Off-pump or on-pump coronary-artery bypass grafting. 
  • Off-pump or on-pump coronary-artery bypass grafting. 
  • Off-pump or on-pump coronary-artery bypass grafting. 
  • Off-pump or on-pump coronary-artery bypass grafting. 
  • Off-pump or on-pump coronary-artery bypass grafting. 
  • Off-pump techniques benefit men and women and narrow the disparity in mortality after coronary bypass grafting. 
  • Off-pump versus on-pump coronary artery bypass surgery and postoperative renal dysfunction. 
  • Omnia munda mundis ('to the pure, all things are pure'). 
  • On-pump versus off-pump coronary artery bypass surgery: cost-effectiveness analysis alongside a multisite trial. 
  • On-pump versus off-pump coronary-artery bypass surgery. 
  • One-year outcome after therapy with tissue plasminogen activator: report from the Thrombolysis and Angioplasty in Myocardial Infarction trial. 
  • Operative Outcomes of Multiple-Arterial Versus Single-Arterial Coronary Bypass Grafting. 
  • Optimal timing of coronary invasive strategy in non-ST-segment elevation acute coronary syndromes: a systematic review and meta-analysis. 
  • Outcome of acute ST-segment elevation myocardial infarction in patients with prior coronary artery bypass surgery receiving thrombolytic therapy. 
  • Outcome of coronary bypass surgery versus coronary angioplasty in diabetic patients with multivessel coronary artery disease. 
  • Outcomes after coronary artery bypass grafting in patients with myocardial infarction, cardiogenic shock and unresponsive neurological state: analysis of the Society of Thoracic Surgeons Database. 
  • Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery. 
  • Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. 
  • Outcomes following revascularization with radial artery bypass grafts: Insights from the PREVENT-IV trial. 
  • Outcomes of Patients Receiving Downstream Revascularization After Initial Medical Management for Non-ST-Segment Elevation Acute Coronary Syndromes (From the TRILOGY ACS Trial). 
  • Outcomes of cardiac surgery in patients > or = 80 years: results from the National Cardiovascular Network. 
  • Outcomes of coronary artery bypass graft surgery in 24,461 patients aged 80 years or older. 
  • Outcomes of early extubation after bypass surgery in the elderly. 
  • Outcomes of noncardiac surgery after coronary bypass surgery or coronary angioplasty in the Bypass Angioplasty Revascularization Investigation (BARI). 
  • Outcomes of off-pump versus on-pump coronary artery bypass grafting: Impact of preoperative risk. 
  • Outcomes of patients with acute coronary syndrome and previous coronary artery bypass grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] trials). 
  • Outcomes of patients with acute coronary syndromes and prior coronary artery bypass grafting: results from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial. 
  • Outcomes of second revascularization procedures after stent implantation. 
  • Oxidative stress and nerve function after cardiopulmonary bypass in patients with diabetes. 
  • PREPARED Study: A Study of Shared Decision-Making for Coronary Artery Disease. 
  • Paramedic transtelephonic communication to cardiologist of clinical and electrocardiographic assessment for rapid reperfusion of ST-elevation myocardial infarction. 
  • Partial Anomalous Hepatic Venous Return: A Systematic Intraoperative Exclusion of Other Serious Diagnoses. 
  • Patient Phenotypes, Cardiovascular Risk, and Ezetimibe Treatment in Patients After Acute Coronary Syndromes (from IMPROVE-IT). 
  • Patient survival characteristics after routine mitral valve repair for ischemic mitral regurgitation. 
  • Patient-Reported Outcomes in Revascularization Decisions for Left-Main Disease: Sharing the EXCELlence. 
  • Patterns of cardiac stress testing after revascularization in community practice. 
  • Patterns of management of atrial fibrillation complicating coronary artery bypass grafting: Results from the PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT-IV) Trial. 
  • Patterns of use of perioperative angiotensin-converting enzyme inhibitors in coronary artery bypass graft surgery with cardiopulmonary bypass: effects on in-hospital morbidity and mortality. 
  • Penetration, Completeness, and Representativeness of The Society of Thoracic Surgeons Adult Cardiac Surgery Database. 
  • Perception of cognitive function in older adults following coronary artery bypass surgery. 
  • Percutaneous coronary intervention in native arteries versus bypass grafts in prior coronary artery bypass grafting patients: a report from the National Cardiovascular Data Registry. 
  • Percutaneous coronary intervention or coronary artery bypass surgery for cardiogenic shock and multivessel coronary artery disease? 
  • Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME). 
  • Percutaneous coronary intervention versus coronary artery bypass grafting for diabetics with multivessel coronary artery disease: the Korean Multicenter Revascularization Registry (KORR). 
  • Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass: outcome of diabetic patients in the AWESOME randomized trial and registry. 
  • Percutaneous coronary intervention versus coronary bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: The VA AWESOME multicenter registry: comparison with the randomized clinical trial. 
  • Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis. 
  • Percutaneous revascularization of an extensively diseased saphenous vein bypass graft with a saphenous vein-covered Palmaz stent. 
  • Percutaneous revascularization of chronic coronary occlusions: an overview. 
  • Percutaneous transluminal coronary angioplasty as palliation for patients considered poor surgical candidates. 
  • Perflubron emulsion (AF0144) augments harvesting of autologous blood: a phase II study in cardiac surgery. 
  • Performance status and outcome after coronary artery bypass grafting in persons aged 80 to 93 years. 
  • Peri-operative platelet function testing: the potential for reducing ischaemic and bleeding risks. 
  • Perioperative Anemia and Transfusions and Late Mortality in Coronary Artery Bypass Patients. 
  • Perioperative Inotrope Therapy and Atrial Fibrillation Following Coronary Artery Bypass Graft Surgery: Evidence of a Racial Disparity. 
  • Perioperative blood pressure control: a prospective survey of patient management in cardiac surgery. 
  • Perioperative cardiac complications and 30-day mortality in patients undergoing intracranial aneurysmal surgery with adenosine-induced flow arrest: a retrospective comparative study. 
  • Perioperative morbidity and mortality in combined vs. staged approaches to carotid and coronary revascularization. 
  • Perioperative outcomes among patients with end-stage renal disease following coronary artery bypass surgery in the USA. 
  • Persistent left superior vena cava and partial anomalous pulmonary venous connection: incidental diagnosis by transesophageal echocardiography during coronary artery bypass surgery. 
  • Personalizing Choice of CABG vs PCI for Multivessel Disease: Predictive Model Falls Short. 
  • Pexelizumab reduces death and myocardial infarction in higher risk cardiac surgical patients. 
  • Platelet Counts, Acute Kidney Injury, and Mortality after Coronary Artery Bypass Grafting Surgery. 
  • Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: the timing based on platelet function strategy to reduce clopidogrel-associated bleeding related to CABG (TARGET-CABG) study. 
  • Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. 
  • Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes. 
  • Pooled RCTs: CABG reduces mortality more than PCI with DES in nondiabetic patients with multivessel CAD. 
  • Postcardiac surgery complications: association of acute renal dysfunction and atrial fibrillation. 
  • Postoperative atrial fibrillation impacts on costs and one-year clinical outcomes: the Veterans Affairs Randomized On/Off Bypass Trial. 
  • Postoperative atrial fibrillation: Sex-specific characteristics and effect on survival. 
  • Postoperative hyperthermia is associated with cognitive dysfunction after coronary artery bypass graft surgery. 
  • Postoperative inotrope and vasopressor use following CABG: outcome data from the CAPS-care study. 
  • Practice Variation Among Hospitals in Revascularization Therapy and Its Association With Procedure-related Mortality. 
  • Practice pattern variability for myocardial revascularization: impact on resource use across 24 centers. 
  • Practice patterns and clinical outcomes after hybrid coronary revascularization in the United States: an analysis from the society of thoracic surgeons adult cardiac database. 
  • Practice patterns and clinical outcomes among non-ST-segment elevation acute coronary syndrome (NSTE-ACS) patients presenting to primary and tertiary hospitals: insights from the EARLY glycoprotein IIb/IIIa inhibition in NSTE-ACS (EARLY-ACS) trial. 
  • Pre- and postoperative anemia, acute kidney injury, and mortality after coronary artery bypass grafting surgery: a retrospective observational study. 
  • Precatheterization Use of P2Y12 Inhibitors in Non-ST-Elevation Myocardial Infarction Patients Undergoing Early Cardiac Catheterization and In-Hospital Coronary Artery Bypass Grafting: Insights From the National Cardiovascular Data Registry®. 
  • Predicting risk-adjusted mortality for CABG surgery: logistic versus hierarchical logistic models. 
  • Predicting survival after coronary revascularization for ischemic cardiomyopathy. 
  • Predicting the future of human gene therapy for cardiovascular diseases: what will the management of coronary artery disease be like in 2005 and 2010? 
  • Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromes. 
  • Prediction of native coronary artery disease progression following PTCA or CABG in the Emory Angioplasty Versus Surgery Trial. 
  • Prediction of operative mortality after valve replacement surgery. 
  • Predictors of 30-day cardiovascular events in patients with prior percutaneous coronary intervention or coronary artery bypass grafting. 
  • Predictors of contemporary coronary artery bypass grafting outcomes. 
  • Predictors of inotrope use during separation from cardiopulmonary bypass. 
  • Predictors of long-term clinical endpoints in patients with refractory angina. 
  • Predictors of long-term survival after coronary artery bypass grafting surgery: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database (the ASCERT study). 
  • Predictors of outcome of percutaneous excimer laser coronary angioplasty of saphenous vein bypass graft lesions. The Percutaneous Excimer Laser Coronary Angioplasty Registry. 
  • Preemptive use of bivalirudin for urgent on-pump coronary artery bypass grafting in patients with potential heparin-induced thrombocytopenia. 
  • Preferences for cardiac tests and procedures may partially explain sex but not race disparities. 
  • Prehospitalization antiplatelet therapy and outcomes after saphenous vein graft intervention. 
  • Preliminary evaluation of the Arctic Sun temperature-controlling system during off-pump coronary artery bypass surgery. 
  • Preliminary report of a genetic basis for cognitive decline after cardiac operations. The Neurologic Outcome Research Group of the Duke Heart Center. 
  • Preliminary report of the effects of complement suppression with pexelizumab on neurocognitive decline after coronary artery bypass graft surgery. 
  • Preliminary report on the association of apolipoprotein E polymorphisms, with postoperative peak serum creatinine concentrations in cardiac surgical patients. 
  • Preliminary report on the interaction of apolipoprotein E polymorphism with aortic atherosclerosis and acute nephropathy after CABG. 
  • Preoperative CYP2D6 metabolism-dependent β-blocker use and mortality after coronary artery bypass grafting surgery. 
  • Preoperative determinants of postoperative costs associated with coronary artery bypass graft surgery. 
  • Preoperative factors associated with worsening in health-related quality of life following coronary artery bypass grafting in the Randomized On/Off Bypass (ROOBY) trial. 
  • Preoperative statin therapy does not reduce cognitive dysfunction after cardiopulmonary bypass. 
  • Preoperative β-blocker use in coronary artery bypass grafting surgery: national database analysis. 
  • Preprocedural white blood cell count and major adverse cardiac events late after percutaneous coronary intervention in saphenous vein grafts. 
  • Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort. 
  • Prevalence of risk factors, and not gender per se, determines short- and long-term survival after coronary artery bypass surgery. 
  • Prevalence, predictors, and impact of conservative medical management for patients with non-ST-segment elevation acute coronary syndromes who have angiographically documented significant coronary disease. 
  • Prevention of cerebral hyperthermia during cardiac surgery by limiting on-bypass rewarming in combination with post-bypass body surface warming: a feasibility study. 
  • Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: six-month follow up and analysis of individual patient data from randomized trials. 
  • Prior coronary artery bypass graft patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. 
  • Priorities in coronary artery bypass grafting: Is midterm survival more dependent on completeness of revascularization or multiple arterial grafts? 
  • Problems and advantages of an observational data base approach to evaluating the effect of therapy on outcome. 
  • Procedural volume as a marker of quality for CABG surgery. 
  • Prognosis and management of anterolateral myocardial infarction in patients with severe left main disease and cardiogenic shock. The left main shock syndrome. 
  • Prognosis of patients taking selective serotonin reuptake inhibitors before coronary artery bypass grafting. 
  • Prognostic effect of bundle branch block related to coronary artery bypass grafting. 
  • Prognostic significance of biomarkers in predicting outcome in patients with coronary artery disease and left ventricular dysfunction: results of the biomarker substudy of the Surgical Treatment for Ischemic Heart Failure trials. 
  • Prognostic significance of bleeding location and severity among patients with acute coronary syndromes. 
  • Prognostic significance of nonsustained ventricular tachycardia identified postoperatively after coronary artery bypass surgery in patients with left ventricular dysfunction. 
  • Prognostic value of Rb-82 positron emission tomography myocardial perfusion imaging in coronary artery bypass patients. 
  • Prognostic value of thallium-201 single-photon emission computed tomography for patients with multivessel coronary artery disease after revascularization (the Emory Angioplasty versus Surgery Trial [EAST]). 
  • Prolonged pulmonary support after cardiac surgery: incidence, risk factors and outcomes: a retrospective cohort study. 
  • Propensity matched comparison of outcomes in older and younger patients after coronary artery bypass graft surgery. 
  • Prophylactic levosimendan in patients with low ejection fraction undergoing coronary artery bypass grafting: A pooled analysis of two multicentre randomised controlled trials. 
  • Prospective randomized trial of normothermic versus hypothermic cardiopulmonary bypass on cognitive function after coronary artery bypass graft surgery. 
  • Prospective, randomized trial comparing blood and oxygenated crystalloid cardioplegia in reoperative coronary artery bypass grafting. 
  • Protamine contributes to myocardial ischemia. 
  • Protecting the brain in coronary artery bypass graft surgery. 
  • Pseudoaneurysms at aortic cannulation site after coronary artery bypass graft: MR findings. 
  • Pulse pressure and long-term survival after coronary artery bypass graft surgery. 
  • Pulse pressure and risk of adverse outcome in coronary bypass surgery. 
  • Quality of life after coronary revascularization in the United States and Canada. 
  • Quality of life and economic outcomes with surgical ventricular reconstruction in ischemic heart failure: results from the Surgical Treatment for Ischemic Heart Failure trial. 
  • Quality of life and recovery after cardiac surgery. 
  • Quality-of-life outcomes with coronary artery bypass graft surgery in ischemic left ventricular dysfunction: a randomized trial. 
  • Quantitation and localization of apolipoproteins [a] and B in coronary artery bypass vein grafts resected at re-operation. 
  • Quantitative echocardiographic assessment of regional wall motion and left ventricular asynchrony with color kinesis in cardiac surgery patients. 
  • Racial differences among high-risk patients presenting with non-ST-segment elevation acute coronary syndromes (results from the SYNERGY trial). 
  • Racial disparity persists after on-pump and off-pump coronary artery bypass grafting. 
  • Racial variation in the use of coronary-revascularization procedures. 
  • Racial variation in the use of coronary-revascularization procedures. Are the differences real? Do they matter? 
  • Radial artery versus saphenous vein versus right internal thoracic artery for coronary artery bypass grafting. 
  • Randomized trials of coronary artery bypass surgery: impact on clinical practice at Duke University Medical Center. 
  • Rationale and design of a randomized trial evaluating an external support device for saphenous vein coronary grafts. 
  • Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative. 
  • Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass. 
  • Recombinant human transgenic antithrombin in cardiac surgery: a dose-finding study. 
  • Recurrent ischemia without warning. Analysis of risk factors for in-hospital ischemic events following successful thrombolysis with intravenous tissue plasminogen activator. 
  • Reduced thrombus burden with abciximab delivered locally before percutaneous intervention in saphenous vein grafts. 
  • Reducing family stress during and after coronary artery bypass surgery. 
  • Reducing the influence of anecdotal reasoning on people's health care decisions: is a picture worth a thousand statistics? 
  • Referral patterns for coronary artery disease treatment: gender bias or good clinical judgment? 
  • Regional patterns of use of a medical management strategy for patients with non-ST-segment elevation acute coronary syndromes: insights from the EARLY ACS Trial. 
  • Regional variation in patient risk factors and mortality after coronary artery bypass grafting. 
  • Rehabilitation of patients following myocardial infarction. 
  • Relation between baseline risk and treatment decisions in non-ST elevation acute coronary syndromes: an examination of international practice patterns. 
  • Relation of Post-Coronary Artery Bypass Graft Creatine Kinase-MB Elevations and New Q Waves With Long-Term Cardiovascular Death in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease. 
  • Relation of early saphenous vein graft failure to outcomes following coronary artery bypass surgery. 
  • Relationship between clinical evaluation of peripheral perfusion and global hemodynamics in adults after cardiac surgery. 
  • Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty. 
  • Relationship between physician and hospital coronary angioplasty volume and outcome in elderly patients. 
  • Relationship between postoperative clopidogrel use and subsequent angiographic and clinical outcomes following coronary artery bypass grafting. 
  • Relationship between vein graft failure and subsequent clinical outcomes after coronary artery bypass surgery. 
  • Relationship of extent of revascularization with angina at one year in the Bypass Angioplasty Revascularization Investigation (BARI). 
  • Relationship of genetic variability and depressive symptoms to adverse events after coronary artery bypass graft surgery. 
  • Relationship of preoperative antiendotoxin core antibodies and adverse outcomes following cardiac surgery. 
  • Relationship of the time interval between cardiac catheterization and elective coronary artery bypass surgery with postprocedural acute kidney injury. 
  • Renal Dysfunction and Arrhythmia Association in Patients Receiving Milrinone After Cardiac Surgery. 
  • Renal artery stenosis is not associated with the development of acute renal failure following coronary artery bypass grafting. 
  • Renal dysfunction and cognitive function after coronary artery bypass graft surgery. 
  • Renal function and coronary bypass surgery in patients with ischemic heart failure. 
  • Reoperation for bleeding in patients undergoing coronary artery bypass surgery: incidence, risk factors, time trends, and outcomes. 
  • Reoperation for coronary artery bypass grafting: anesthetic challenge. 
  • Reperfusion and revascularization strategies for coronary artery disease in women. 
  • Reply: To PMID 24360877. 
  • Reply: When Will We Stop Debating on the Value of TEE in CABG? 
  • Resident versus attending surgeon graft patency and clinical outcomes in on- versus off-pump coronary artery bypass surgery. 
  • Resource use and cost of initial coronary revascularization. Coronary angioplasty versus coronary bypass surgery. 
  • Resource use trajectories for aged medicare beneficiaries with complex coronary conditions. 
  • Response to Letters Regarding Article, "Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial". 
  • Response to Letters Regarding Article, "Saphenous Vein Graft Failure After Coronary Artery Bypass Surgery: Insights From PREVENT IV". 
  • Response to the Letter to the Editor titled "Atrial fibrillation in patients with acute coronary syndromes". 
  • Retrograde-delivered cardioplegia is not distributed equally to the right ventricular free wall and septum. 
  • Revascularization Strategies and Outcomes in Elderly Patients With Multivessel Coronary Disease. 
  • Revascularization Trends in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease Presenting With Non-ST Elevation Myocardial Infarction: Insights From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get with the Guidelines (NCDR ACTION Registry-GWTG). 
  • Revascularization for heart failure. 
  • Revascularization for unprotected left main stem coronary artery stenosis stenting or surgery. 
  • Revascularization improves survival in ischemic cardiomyopathy regardless of electrocardiographic criteria for prior small-to-medium myocardial infarcts. 
  • Revascularization in stable coronary artery disease. 
  • Revascularization in stable coronary disease: evidence and uncertainties. 
  • Right thoracotomy for reoperative right coronary artery bypass procedures. 
  • Right ventricular rupture during off-pump coronary bypass surgery. 
  • Risk factors for conversion to cardiopulmonary bypass during off-pump coronary artery bypass surgery. 
  • Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis: results from GUSTO-I. 
  • Risk factors in coronary artery bypass surgery. 
  • Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators. 
  • Risk index for perioperative renal dysfunction/failure: critical dependence on pulse pressure hypertension. 
  • Risk stratification for adverse economic outcomes in cardiac surgery. 
  • Risk-adjusted short- and long-term outcomes for on-pump versus off-pump coronary artery bypass surgery. 
  • Risk-benefit trade-offs in revascularisation choices. 
  • Rivaroxaban Plus Aspirin After CABG: More Evidence Is Needed. 
  • Role of nuclear imaging after coronary revascularization. 
  • SF-36 PCS benefit-cost ratio of lumbar fusion comparison to other surgical interventions: a thought experiment. 
  • ST segment shift in unstable angina: pathophysiology and association with coronary anatomy and hospital outcome. 
  • SYNTAX Score and Long-Term Outcomes: The BARI-2D Trial. 
  • Safe application of a restrictive transfusion protocol in moderate-risk patients undergoing cardiac operations. 
  • Safety and Feasibility of Simultaneous Transcarotid Revascularization With Flow Reversal and Coronary Artery Bypass Grafting for Concomitant Carotid Artery Stenosis and Coronary Artery Disease. 
  • Safety and efficacy of cangrelor, an intravenous, short-acting platelet inhibitor in patients requiring coronary artery bypass surgery. 
  • Safety and efficacy of sonicated albumin microspheres in perfusion and vein graft patency assessments. 
  • Safety of selective serotonin reuptake inhibitor use prior to coronary artery bypass grafting. 
  • Salvage Coronary Artery Bypass Predicts Increased Mortality During Aortic Root Operation. 
  • Saphenous vein graft failure after coronary artery bypass surgery: insights from PREVENT IV. 
  • Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions. 
  • Saphenous vein graft failure and clinical outcomes: toward a surrogate end point in patients following coronary artery bypass surgery? 
  • Saphenous vein grafts with multiple versus single distal targets in patients undergoing coronary artery bypass surgery: one-year graft failure and five-year outcomes from the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV trial. 
  • Seasonal Incidence of Emergent Coronary Artery Bypass Grafting Surgery. 
  • Secondary prevention after coronary artery bypass graft surgery: findings of a national randomized controlled trial and sustained society-led incorporation into practice. 
  • Secondary surgical-site infection after coronary artery bypass grafting: A multi-institutional prospective cohort study. 
  • Selection of patients for coronary angiography and coronary revascularization early after myocardial infarction: is there evidence for a gender bias? 
  • Selection of surgical or percutaneous coronary intervention provides differential longevity benefit. 
  • Serial changes in left ventricular ejection fraction in the early hours after aortocoronary bypass grafting. 
  • Serial prognostic capabilities of electrocardiographic indices of infarcted and hibernating myocardium in predicting short- and long-term outcome following coronary artery bypass surgery. 
  • Serum creatinine patterns in coronary bypass surgery patients with and without postoperative cognitive dysfunction. 
  • Severe coronary artery disease: is there a place for percutaneous coronary intervention? 
  • Severity of Remodeling, Myocardial Viability, and Survival in Ischemic LV Dysfunction After Surgical Revascularization. 
  • Sex Difference in Patients With Ischemic Heart Failure Undergoing Surgical Revascularization: Results From the STICH Trial (Surgical Treatment for Ischemic Heart Failure). 
  • Sex Differences in Coronary Artery Bypass Grafting Techniques: A Society of Thoracic Surgeons Database Analysis. 
  • Sex differences in outcomes after coronary artery bypass grafting: a pooled analysis of individual patient data. 
  • Sex-Related Outcomes of Medical, Percutaneous, and Surgical Interventions for Coronary Artery Disease: JACC Focus Seminar 3/7. 
  • Sex-related differences in outcomes after coronary artery bypass surgery-A patient-level pooled analysis of randomized controlled trials: rationale and study protocol. 
  • Sexual quality of life in patients undergoing coronary artery bypass graft surgery. 
  • Sexuality and the older bypass patient. 
  • Short- and long-term outcomes in patients undergoing valve surgery with end-stage renal failure receiving chronic hemodialysis. 
  • Short- and long-term outcomes of coronary stenting in women versus men: results from the National Cardiovascular Data Registry Centers for Medicare & Medicaid services cohort. 
  • Short-term outcomes of balloon angioplasty versus stent placement for patients undergoing primary percutaneous coronary intervention: Implications for patients requiring early coronary artery bypass surgery. 
  • Significance of a coronary artery with thrombolysis in myocardial infarction grade 2 flow "patency" (outcome in the thrombolysis and angioplasty in myocardial infarction trials). Thrombolysis and Angioplasty in Myocardial Infarction Study Group. 
  • Simultaneous restenosis of Taxus and Cypher drug-eluting stents. 
  • Single- Versus Multicenter Surgeons' Risk-Adjusted Coronary Artery Bypass Graft Procedural Outcomes. 
  • Society of Thoracic Surgeons Risk Score and EuroSCORE-2 Appropriately Assess 30-Day Postoperative Mortality in the STICH Trial and a Contemporary Cohort of Patients With Left Ventricular Dysfunction Undergoing Surgical Revascularization. 
  • Special Articles: 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 
  • Specificity of procedure volume and in-hospital mortality association. 
  • Spontaneous Coronary Artery Dissection: Current State of the Science: A Scientific Statement From the American Heart Association. 
  • Spontaneous multivessel coronary artery dissection in a young asymptomatic patient. 
  • Standardizing definitions for hybrid coronary revascularization. 
  • Staphylococcus aureus bacteremia after median sternotomy: clinical utility of blood culture results in the identification of postoperative mediastinitis. 
  • Statins--is there potential for uncovering new benefits (or detriments)? 
  • Storage age of transfused platelets and outcomes after cardiac surgery. 
  • Stress imaging use and repeat revascularization among medicare patients with high-risk coronary artery disease. 
  • Successful aneurysm resection and coronary artery revascularization following saphenous vein graft aneurysm rupture. 
  • Successful linking of the Society of Thoracic Surgeons adult cardiac surgery database to Centers for Medicare and Medicaid Services Medicare data. 
  • Successful linking of the Society of Thoracic Surgeons database to social security data to examine survival after cardiac operations. 
  • Sudden Cardiac Death in Patients With Ischemic Heart Failure Undergoing Coronary Artery Bypass Grafting: Results From the STICH Randomized Clinical Trial (Surgical Treatment for Ischemic Heart Failure). 
  • Supraventricular conduction abnormalities following cardiac operations. A complication of inadequate atrial preservation. 
  • Surgeon judgment and utility of transit time flow probes in coronary artery bypass grafting surgery. 
  • Surgeons' economic profiles: can we get the "right" answers? 
  • Surgery. Translating trials to clinical practice in cardiac surgery. 
  • Surgical antimicrobial prophylaxis: is the glass half empty or more than 99% full? 
  • Surgical revascularization is associated with maximal survival in patients with ischemic mitral regurgitation: a 20-year experience. 
  • Surgical survival benefits for coronary disease patients with left ventricular dysfunction. 
  • Surgical treatment of moderate ischemic mitral regurgitation. 
  • Surgical treatment of moderate ischemic mitral regurgitation. 
  • Surgical versus percutaneous coronary revascularization for multivessel disease in diabetic patients with non-ST-segment-elevation acute coronary syndrome: analysis from the Acute Catheterization and Early Intervention Triage Strategy trial. 
  • Survival after coronary revascularization, with and without mitral valve surgery, in patients with ischemic mitral regurgitation. 
  • Survival and cardiac event rates in the first year after emergency coronary angioplasty for acute myocardial infarction. 
  • Survival of coronary artery disease patients with stable pain and normal left ventricular function treated medically or surgically at Duke University. 
  • Survival prognosis and surgical management of ischemic mitral regurgitation. 
  • Suspected protamine allergy: diagnosis and management for coronary artery surgery. 
  • Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab: one-year outcome in the EPILOG trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade. 
  • Symmetry aortic connector devices and acute renal injury: a comparison of renal dysfunction after three different aortocoronary bypass surgery techniques. 
  • Systemic air embolism during off-pump coronary artery bypass surgery. 
  • Systolic left ventricular function after reperfusion therapy for acute myocardial infarction. Analysis of determinants of improvement. The TAMI Study Group. 
  • TIMI IIB follow-up. Lessons for clinicians and investigators. 
  • Temperature during coronary artery bypass surgery affects quality of life. 
  • Temporal Trends in Utilization of Cardiac Therapies and Outcomes for Myocardial Infarction by Degree of Chronic Kidney Disease: A Report From the NCDR Chest Pain-MI Registry. 
  • Temporal changes in the use of blood products for coronary artery bypass graft surgery in North America: an analysis of the Society of Thoracic Surgeons Adult Cardiac Database. 
  • Temporal trends for secondary prevention measures among patients hospitalized with coronary artery disease. 
  • Temporomandibular Joint Pain Presentation of Myocardial Ischemia. 
  • Ten-Year Outcomes After Coronary Artery Bypass Grafting According to Age in Patients With Heart Failure and Left Ventricular Systolic Dysfunction: An Analysis of the Extended Follow-Up of the STICH Trial (Surgical Treatment for Ischemic Heart Failure). 
  • Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial. 
  • Testing an intervention to increase cardiac rehabilitation enrollment after coronary artery bypass grafting. 
  • The Aggressive Cholesterol Therapy to Inhibit Vein Graft Events trial: To continue or not? How to answer the question. 
  • The Association of Previous Revascularization With In-Hospital Outcomes in Acute Myocardial Infarction Patients: Results From the National Cardiovascular Data Registry. 
  • The Axillary Intra-Aortic Balloon Pump as a Bridge to Recovery Allows Early Ambulation in Long-Term Use: Case Series and Literature Review. 
  • The Early Invasive Strategy in Acute Coronary Syndromes: Should the Guideline Recommendations Be Revisited? 
  • The Hostile Thoracic Aorta: Management Considerations for Severe Aortic Atheroma in a Challenging Case of Coronary Artery Bypass Grafting and Mitral Valve Replacement. 
  • The Internet Tracking Registry of Acute Coronary Syndromes (i*trACS): a multicenter registry of patients with suspicion of acute coronary syndromes reported using the standardized reporting guidelines for emergency department chest pain studies. 
  • The Mini Mental State Exam as a predictor of neuropsychological functioning after cardiac surgery. 
  • The Monitoring and Actualization of Noetic TRAining the MANTRA Study, a randomized controlled study of healing interventions. 
  • The PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) trial: study rationale, design, and baseline patient characteristics. 
  • The Racial Paradox in Multiarterial Conduit Utilization for Coronary Artery Bypass Grafting. 
  • The STICH trial (Surgical Treatment for Ischemic Heart Failure): mode-of-death results. 
  • The STS AVR+CABG composite score: a report of the STS Quality Measurement Task Force. 
  • The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery. 
  • The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 3--valve plus coronary artery bypass grafting surgery. 
  • The Society of Thoracic Surgeons Adult Cardiac Surgery Database: 2018 Update on Research: Outcomes Analysis, Quality Improvement, and Patient Safety. 
  • The Society of Thoracic Surgeons Adult Cardiac Surgery Database: 2021 Update on Echocardiography. 
  • The Society of Thoracic Surgeons Composite Measure of Individual Surgeon Performance for Adult Cardiac Surgery: A Report of The Society of Thoracic Surgeons Quality Measurement Task Force. 
  • The Society of Thoracic Surgeons Coronary Artery Bypass Graft Composite Measure: 2021 Methodology Update. 
  • The Society of Thoracic Surgeons Mitral Valve Repair/Replacement Plus Coronary Artery Bypass Grafting Composite Score: A Report of The Society of Thoracic Surgeons Quality Measurement Task Force. 
  • The Society of Thoracic Surgeons voluntary public reporting initiative: the first 4 years. 
  • The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. 
  • The VB-1 catheter: an improved catheter for difficult-to-engage internal mammary artery grafts. 
  • The Value of Echocardiography in Unexpected Valve Disease in a Patient With Ischemic Cardiomyopathy: Less Is Not Always the Right Answer. 
  • The association between blood pressure and long-term outcomes of patients with ischaemic cardiomyopathy with and without surgical revascularization: an analysis of the STICH trial. 
  • The association between coronary graft patency and clinical status in patients with coronary artery disease. 
  • The association of epsilon-aminocaproic acid with postoperative decrease in creatinine clearance in 1502 coronary bypass patients. 
  • The association of lowest hematocrit during cardiopulmonary bypass with acute renal injury after coronary artery bypass surgery. 
  • The association of patent foramen ovale and atrial fibrillation after coronary artery bypass graft surgery. 
  • The baby and the bathwater: is Ouabain's biomarker value lost without evidence of a causal role in acute kidney injury? 
  • The benefit of adding ezetimibe to statin therapy in patients with prior coronary artery bypass graft surgery and acute coronary syndrome in the IMPROVE-IT trial. 
  • The bispectral index in the diagnosis of perioperative stroke: a case report and discussion. 
  • The changing survival benefits of coronary revascularization over time. 
  • The concordance of intraoperative left ventricular wall-motion abnormalities and electrocardiographic S-T segment changes: association with outcome after coronary revascularization. Multicenter Study of Perioperative Ischemia (McSPI) Research Group. 
  • The current practice of intra-aortic balloon counterpulsation: results from the Benchmark Registry. 
  • The effect of PEEP on left ventricular diastolic dimensions and systolic performance following myocardial revascularization. 
  • The effect of aprotinin on outcome after coronary-artery bypass grafting. 
  • The effect of cardiopulmonary bypass and inspired oxygen concentration on left ventricular contrast opacification with optison, a second-generation ultrasound contrast agent. 
  • The effect of crossovers on estimates of survival in medically treated patients with coronary artery disease. 
  • The effect of duration of hypothermic cardioplegia on ventricular function. 
  • The effect of managed care penetration on the treatment of AMI in the fee-for-service Medicare population. 
  • The effect of pulsatile perfusion on preservation of left ventricular function after aortocoronary bypass grafting. 
  • The effects of New York's bypass surgery provider profiling on access to care and patient outcomes in the elderly. 
  • The efficacy and resource utilization of remifentanil and fentanyl in fast-track coronary artery bypass graft surgery: a prospective randomized, double-blinded controlled, multi-center trial. 
  • The evaluation of treatment when center-specific selection criteria vary with respect to patient risk. 
  • The evolution of medical and surgical therapy for coronary artery disease. A 15-year perspective. 
  • The great imitator: Rocky Mountain spotted fever occurring after hospitalization for unrelated illnesses. 
  • The health care burden of unstable angina. 
  • The impact of coronary artery disease on carotid endarterectomy. 
  • The impact of for-profit hospital status on the care and outcomes of patients with non-ST-segment elevation myocardial infarction: results from the CRUSADE Initiative. 
  • The impact of high-risk cases on hospitals' risk-adjusted coronary artery bypass grafting mortality rankings. 
  • The impact of intraoperative echocardiography on clinical outcomes following adult cardiac surgery. 
  • The impact of postoperative atrial fibrillation on neurocognitive outcome after coronary artery bypass graft surgery. 
  • The inclusion of patient testimonials in decision aids: effects on treatment choices. 
  • The influence of collateral flow on the antegrade and retrograde distribution of cardioplegia in patients with an occluded right coronary artery. 
  • The influence of time on the response to dopamine after coronary artery bypass grafting: assessment of left ventricular performance and contractility using pressure/dimension analyses. 
  • The natural history of single-vessel chronic coronary occlusion: a 25-year experience. 
  • The nature of treatment selection in coronary artery disease. Experience with medical and surgical treatment of a chronic disease. 
  • The optimal antithrombotic regimen to prevent post-CABG adverse events: an ongoing controversy. 
  • The quest for the "Holy Grail" of ischemic stroke cytoprotection: Statins may not be the answer. 
  • The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial. 
  • The relation between the volume of coronary angioplasty procedures at hospitals treating Medicare beneficiaries and short-term mortality. 
  • The relationship of hospital market concentration, costs, and quality for major surgical procedures. 
  • The restricted cubic spline as baseline hazard in the proportional hazards model with step function time-dependent covariables. 
  • The rewarming rate and increased peak temperature alter neurocognitive outcome after cardiac surgery. 
  • The risk of vitreous hemorrhage caused by coronary artery bypass grafting in proliferative diabetic retinopathy. 
  • The role of robotics in cardiac surgery: a systematic review. 
  • The significance of pre-operative coronary interventions on outcome after pancreas transplantation. 
  • The usage patterns of cardiac bedside markers employing point-of-care testing for troponin in non-ST-segment elevation acute coronary syndrome: results from CRUSADE. 
  • The use of high-fidelity human patient simulation as an evaluative tool in the development of clinical research protocols and procedures. 
  • The use of patient mix-adjusted control charts to compare in-hospital costs of care. 
  • The value of early out-patient cardiac exercise programmes for the elderly in comparison with other selected age groups. 
  • The value of patient-reported health status in predicting short-term outcomes after coronary artery bypass graft surgery. 
  • Therapeutic applications of transcription factor decoy oligonucleotides. 
  • Third universal definition of myocardial infarction. 
  • Three-year outcomes of multivessel revascularization in very elderly acute coronary syndrome patients. 
  • Thrombin-receptor antagonist vorapaxar in acute coronary syndromes. 
  • Thrombolysis in unstable angina. Randomized double-blind trial of t-PA and placebo. 
  • Thrombomodulin gene variants are associated with increased mortality after coronary artery bypass surgery in replicated analyses. 
  • Ticagrelor Following Coronary Artery Bypass Grafting: For Better Vein Graft Patency or Better Patient Outcomes? 
  • Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial. 
  • Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial. 
  • Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study. 
  • Timing of Coronary Bypass Surgery in Patients Receiving Clopidogrel: The Role of VerifyNow. 
  • Timing of in-hospital coronary artery bypass graft surgery for non-ST-segment elevation myocardial infarction patients results from the National Cardiovascular Data Registry ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines). 
  • Tissue engineered small-diameter vascular grafts. 
  • To Pretreat or Not to Pretreat (With Oral P2Y12 Antagonists)? That is the Question. 
  • Toward a new frontier in cardiac surgery. 
  • Toward improved coronary artery revascularization: is this as good as it gets? 
  • Transcatheter aortic valve replacement has improved short-term but similar midterm outcomes in isolated aortic valve replacement after prior coronary artery bypass grafting. 
  • Transcatheter or Surgical Aortic Valve Replacement in Patients With Prior Coronary Artery Bypass Grafting. 
  • Transcerebral platelet activation after aortic cross-clamp release is linked to neurocognitive decline. 
  • Transcranial Doppler blood flow velocity versus 133Xe clearance cerebral blood flow during mild hypothermic cardiopulmonary bypass. 
  • Transcranial Doppler emboli count predicts rise in creatinine after coronary artery bypass graft surgery. 
  • Transesophageal Echocardiography in Patients Undergoing Coronary Artery Bypass Graft Surgery. 
  • Transfusion outcomes in patients undergoing coronary artery bypass grafting treated with prasugrel or clopidogrel: TRITON-TIMI 38 retrospective data analysis. 
  • Transluminal extraction catheter for the treatment of diseased saphenous vein grafts: a multicenter experience. 
  • Transluminal intracoronary reperfusion catheter: a device to maintain coronary perfusion between failed coronary angioplasty and emergency coronary bypass surgery. 
  • Transpulmonary lactate gradient after hypothermic cardiopulmonary bypass. 
  • Treatment disparities in the care of patients with and without diabetes presenting with non-ST-segment elevation acute coronary syndromes. 
  • Treatment of postoperative hypertension after coronary artery bypass surgery. Double-blind comparison of intravenous isradipine and sodium nitroprusside. 
  • Treatment of reinfarction after thrombolytic therapy for acute myocardial infarction: an analysis of outcome and treatment choices in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (gusto I) and assessment of the safety of a new thrombolytic (assent 2) studies. 
  • Treatment selection for coronary artery disease: The collision of a belief system with evidence. 
  • Treatment selection for coronary artery disease: the collision of a belief system with evidence. 
  • Trends in Robotic-Assisted Coronary Artery Bypass Grafts: A Study of The Society of Thoracic Surgeons Adult Cardiac Surgery Database, 2006 to 2012. 
  • Trends in acute renal failure associated with coronary artery bypass graft surgery in the United States. 
  • Trends in cardiac surgery-associated acute renal failure in the United States: a disproportionate increase after heart transplantation. 
  • Trends in emergency coronary artery bypass grafting after percutaneous coronary intervention, 1994-2003. 
  • Trends in isolated coronary artery bypass grafting: an analysis of the Society of Thoracic Surgeons adult cardiac surgery database. 
  • Trends in postoperative length of stay after bypass surgery. 
  • Trends in quality of care for patients with acute myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006. 
  • Trends in the surgical treatment of ischemic mitral regurgitation: effects of mitral valve repair on hospital mortality. 
  • Trends in the use of diagnostic coronary angiography, percutaneous coronary intervention, and coronary artery bypass graft surgery across North Carolina. 
  • Trends in use of off-pump coronary artery bypass grafting: Results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database. 
  • Trends in utilization of coronary artery bypass surgery and associated outcomes: Alberta, Manitoba, and Nova Scotia. 
  • Twenty-five-year outcomes after multiple internal thoracic artery bypass. 
  • Two-Year Outcomes of Surgical Treatment of Moderate Ischemic Mitral Regurgitation. 
  • Ultrasound assessment of left ventricular function following aortocoronary saphenous vein bypass grafting. 
  • Ultrastructural studies of unstable angina in living man. 
  • Understanding racial variation in the use of coronary revascularization procedures: the role of clinical factors. 
  • Unexpected intraoperative diagnosis of pulmonary embolism by transesophageal echocardiography. 
  • Unreliability of hemodynamic indexes of left ventricular size during cardiac surgery. 
  • Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction. Results of a randomized trial. The Randomized IABP Study Group. 
  • Use of both internal thoracic arteries in diabetic patients increases deep sternal wound infection. 
  • Use of common antiplatelet drugs for vascular diseases. 
  • Use of computed tomography (CT) for preoperative planning in patients undergoing coronary artery bypass grafting (CABG). 
  • Use of continuous quality improvement to increase use of process measures in patients undergoing coronary artery bypass graft surgery: a randomized controlled trial. 
  • Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. 
  • Use of renin-angiotensin system blockers in acute coronary syndromes: findings from Get With the Guidelines-Coronary Artery Disease Program. 
  • Use of the Internet by patients before and after cardiac surgery: telephone survey. 
  • Usefulness of serial radionuclide angiography in predicting cardiac death after coronary artery bypass grafting and comparison with clinical and cardiac catheterization data. 
  • Using Medicare claims data to assess provider quality for CABG surgery: does it work well enough? 
  • Utility of a simple algorithm to grade diastolic dysfunction and predict outcome after coronary artery bypass graft surgery. 
  • Utility of consecutive repeat HIT ELISA testing for heparin-induced thrombocytopenia. 
  • Utility of observation units for young emergency department chest pain patients. 
  • Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. 
  • Utilization, Characteristics, and In-Hospital Outcomes of Coronary Artery Bypass Grafting in Patients With ST-Segment-Elevation Myocardial Infarction: Results From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines. 
  • Validating a 3-point prediction rule for surgical site infection after coronary artery bypass surgery. 
  • Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER Trial. 
  • Validation of European System for Cardiac Operative Risk Evaluation (EuroSCORE) in North American cardiac surgery. 
  • Value and limitation of biplane rest and exercise radionuclide angiography for assessing individual bypass grafts: a prospective study. 
  • Value of radionuclide angiography for predicting specific cardiac events after acute myocardial infarction. 
  • Variability in cost of coronary bypass surgery in New York State: potential for cost savings. 
  • Variation in perioperative vasoactive therapy in cardiovascular surgical care: data from the Society of Thoracic Surgeons. 
  • Variation in tracheal reintubations among patients undergoing cardiac surgery across Washington state hospitals. 
  • Variation in use of blood transfusion in coronary artery bypass graft surgery. 
  • Variation in ventilation time after coronary artery bypass grafting: an analysis from the society of thoracic surgeons adult cardiac surgery database. 
  • Variations in coronary procedure utilization depending on body mass index. 
  • Vascular factors and risk for neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study. 
  • Vascular factors predict rate of progression in Alzheimer disease. 
  • Vein graft preservation solutions, patency, and outcomes after coronary artery bypass graft surgery: follow-up from the PREVENT IV randomized clinical trial. 
  • Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome). 
  • Vulnerable plaque intervention: State of the art. 
  • Walking pace is inversely associated with risk of death and cardiovascular disease: The Physicians' Health Study. 
  • Whole blood gene expression testing for coronary artery disease in nondiabetic patients: major adverse cardiovascular events and interventions in the PREDICT trial. 
  • Worldwide Trends in Multi-arterial Coronary Artery Bypass Grafting Surgery 2004-2014: A Tale of 2 Continents. 
  • [Coronary bypass surgery remains to be effective in the treatment of patients with coronary artery disease and left ventricular dysfunction]. 
  • [Is coronary magnetic resonance angiography already a clinically useful diagnostic tool?]. 
  • [Prayers for patients with internal and cardiological diseases--an applicable therapeutic method?]. 
  • epsilon-Aminocaproic acid plasma levels during cardiopulmonary bypass. 
• 

  Keywords of People

  • Alexander, John Hunter Peel, Professor of Medicine, Medicine, Cardiology
  • Brennan, J. Matthew, Associate Professor of Medicine, Medicine, Cardiology
  • Curtis, Lesley H., Professor in Population Health Sciences, Medicine, General Internal Medicine
  • DeLong, Elizabeth Ray, Professor Emeritus of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics
  • Laskowitz, Daniel Todd, Professor of Neurology, Duke Science & Society
  • Milano, Carmelo Alessio, Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery, Surgery, Cardiovascular and Thoracic Surgery
  • O'Connor, Christopher Michael, Adjunct Professor in the Department of Medicine, Medicine, Clinical Pharmacology
  • Olsen, Maren Karine, Professor of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics
  • Patel, Uptal Dinesh, Adjunct Professor in the Department of Medicine, Medicine, Nephrology
  • Yancy Jr., William Samuel, Professor of Medicine, Medicine, General Internal Medicine